reaction_smiles,sources,reactants,products,solvents,catalyst,stages
"['[Cl:1][C:2]1[CH:10]=[CH:9][C:8]([N+:11]([O-:13])=[O:12])=[CH:7][C:3]=1[C:4]([OH:6])=O.C(N1C=CN=C1)([N:16]1[CH:20]=[CH:19]N=C1)=O.C(N(CC)CC)C', 'C(N)C', '[CH2:20]([NH:16][C:4](=[O:6])[C:3]1[CH:7]=[C:8]([N+:11]([O-:13])=[O:12])[CH:9]=[CH:10][C:2]=1[Cl:1])[CH3:19]']","['US20010027200A1', '0133', '2-Chloro-5-nitrobenzoic acid (20 g, 100 mmol) in TBF (200 mL) was treated with carbonyldiimidazole (CDI) (17.8 g, 110 mmol) and triethylamine (16 mL, 110 mmol) at room temperature. After 1 hr, a solution of ethylamine (70% in water, 10 mL) was added and the mixture was stirred for 18 h. Solvent was removed by evaporation and the residue was dissolved in methylene chloride, washed with 3% KOH solution followed by water (three times) until the aqueous phase extracts were colorless. The organic phase was dried over MgSO4, filtered, and the filtrate was concentrated to provide 10.4 g of N-ethyl-2-chloro-5-nitrobenzamide as light yellow crystals.']","[{'chemical_names': ['2-Chloro-5-nitrobenzoic acid'], 'identifiers': ['smiles:O=C(O)c1cc([N+](=O)[O-])ccc1Cl', 'inchi:InChI=1S/C7H4ClNO4/c8-6-2-1-4(9(12)13)3-5(6)7(10)11/h1-3H,(H,10,11)'], 'amounts': ['100 mmol', '20 g'], 'appearances': []}, {'chemical_names': ['carbonyldiimidazole'], 'identifiers': ['smiles:O=C(n1ccnc1)n1ccnc1', 'inchi:InChI=1S/C7H6N4O/c12-7(10-3-1-8-5-10)11-4-2-9-6-11/h1-6H'], 'amounts': ['110 mmol', '17.8 g'], 'appearances': []}, {'chemical_names': ['triethylamine'], 'identifiers': ['smiles:CCN(CC)CC', 'inchi:InChI=1S/C6H15N/c1-4-7(5-2)6-3/h4-6H2,1-3H3'], 'amounts': ['110 mmol', '16 mL'], 'appearances': []}]","[{'chemical_names': ['N-ethyl-2-chloro-5-nitrobenzamide'], 'identifiers': ['smiles:CCNC(=O)c1cc([N+](=O)[O-])ccc1Cl', 'inchi:InChI=1S/C9H9ClN2O3/c1-2-11-9(13)7-5-6(12(14)15)3-4-8(7)10/h3-5H,2H2,1H3,(H,11,13)'], 'amounts': ['10.4 g', '45.5'], 'appearances': ['light yellow']}]","[{'chemical_names': ['TBF'], 'identifiers': [], 'amounts': ['200 mL'], 'appearances': []}, {'chemical_names': ['ethylamine'], 'identifiers': ['smiles:CCN', 'inchi:InChI=1S/C2H7N/c1-2-3/h2-3H2,1H3'], 'amounts': ['10 mL'], 'appearances': []}]",[],"['step 1:2-Chloro-5-nitrobenzoic acid (20 g, 100 mmol) in TBF (200 mL) was treated with carbonyldiimidazole (CDI) (17.8 g, 110 mmol) and triethylamine (16 mL, 110 mmol) at room temperature', 'step 1 properties:Temperature:room temperature', 'step 2:After 1 hr', 'step 2 properties:Time:3600', 'step 3:a solution of ethylamine (70% in water, 10 mL) was added', 'step 4:the mixture was stirred for 18 h', 'step 4 properties:Time:64800', 'step 5:Solvent was removed by evaporation', 'step 6:the residue was dissolved in methylene chloride', 'step 7:washed with 3% KOH solution', 'step 8:The organic phase was dried over MgSO4', 'step 9:filtered', 'step 10:the filtrate was concentrated', 'step 11:to provide 10.4 g of N-ethyl-2-chloro-5-nitrobenzamide as light yellow crystals']"
"['F[C:2]1[N:11]=[CH:10][C:9]2[C:8]([NH:12][C:13]3[CH:18]=[CH:17][CH:16]=[C:15]([Br:19])[CH:14]=3)=[N:7][CH:6]=[N:5][C:4]=2[CH:3]=1.[CH2:20]([N:22](CC)[CH2:23]C)C.Cl.CNC', 'C(O)(C)C', '[CH3:20][N:22]([CH3:23])[C:2]1[N:11]=[CH:10][C:9]2[C:8]([NH:12][C:13]3[CH:18]=[CH:17][CH:16]=[C:15]([Br:19])[CH:14]=3)=[N:7][CH:6]=[N:5][C:4]=2[CH:3]=1 |f:2.3|']","['US20010027197A1', '0361', 'A mixture of 7-fluoro-4-(3-bromoanilino)pyrido[4,3-d]pyrimidine (101 mg, 0.32 mmol), triethylamine (4.4 mL, 32 mmole) and dimethylamine hydrochloride (2.58 g, 32 mmol) in isopropanol (30 mL) contained in a steel bomb is stirred at 100° C. (oil bath) for 4 h. The resulting solution is concentrated under vacuum, basified with aqueous Na2CO3 and diluted with water to give a solid. Filtration and recrystallisation from MeOH/CHCl3 gives 7-dimethylamino-4-(3-bromoanilino)pyrido[4,3-d]pyrimidine (102 mg, 94%) as a pale yellow solid. 1H NMR (DMSO) δ 9.93 (1H, brs), 9.42 (1H, s), 8.48 (1H, s), 8.19 (1H, s), 7.85 (1H, d, J=7.7 Hz), 7.35 (1H, t, J=7.9 Hz), 7.30 (1H, brd, J=7.8 Hz), 6.53 (1H, s), 3.16 (6H, s).']","[{'chemical_names': ['7-fluoro-4-(3-bromoanilino)pyrido[4,3-d]pyrimidine'], 'identifiers': ['smiles:Fc1cc2ncnc(Nc3cccc(Br)c3)c2cn1', 'inchi:InChI=1S/C13H8BrFN4/c14-8-2-1-3-9(4-8)19-13-10-6-16-12(15)5-11(10)17-7-18-13/h1-7H,(H,17,18,19)'], 'amounts': ['0.32 mmol', '101 mg'], 'appearances': []}, {'chemical_names': ['triethylamine'], 'identifiers': ['smiles:CCN(CC)CC', 'inchi:InChI=1S/C6H15N/c1-4-7(5-2)6-3/h4-6H2,1-3H3'], 'amounts': ['32 mmole', '4.4 mL'], 'appearances': []}, {'chemical_names': ['dimethylamine hydrochloride'], 'identifiers': ['smiles:CNC.Cl', 'inchi:InChI=1S/C2H7N.ClH/c1-3-2;/h3H,1-2H3;1H'], 'amounts': ['32 mmol', '2.58 g'], 'appearances': []}, {'chemical_names': ['steel'], 'identifiers': [], 'amounts': [], 'appearances': []}]","[{'chemical_names': ['7-dimethylamino-4-(3-bromoanilino)pyrido[4,3-d]pyrimidine'], 'identifiers': ['smiles:CN(C)c1cc2ncnc(Nc3cccc(Br)c3)c2cn1', 'inchi:InChI=1S/C15H14BrN5/c1-21(2)14-7-13-12(8-17-14)15(19-9-18-13)20-11-5-3-4-10(16)6-11/h3-9H,1-2H3,(H,18,19,20)'], 'amounts': ['102 mg', '94%', '92.6'], 'appearances': ['pale yellow']}]","[{'chemical_names': ['isopropanol'], 'identifiers': ['smiles:CC(C)O', 'inchi:InChI=1S/C3H8O/c1-3(2)4/h3-4H,1-2H3'], 'amounts': ['30 mL'], 'appearances': []}]",[],"['step 1:A mixture of 7-fluoro-4-(3-bromoanilino)pyrido[4,3-d]pyrimidine (101 mg, 0.32 mmol), triethylamine (4.4 mL, 32 mmole) and dimethylamine hydrochloride (2.58 g, 32 mmol) in isopropanol (30 mL)', 'step 2:is stirred at 100° C. (oil bath) for 4 h', 'step 2 properties:Time:14400', 'step 2 properties:Temperature:100', 'step 3:The resulting solution is concentrated under vacuum', 'step 4:diluted with water', 'step 5:to give a solid', 'step 6:Filtration and recrystallisation from MeOH/CHCl3', 'step 7:gives 7-dimethylamino-4-(3-bromoanilino)pyrido[4,3-d]pyrimidine (102 mg, 94%) as a pale yellow solid']"
"['[NH2:1][C:2]1[N:11]=[CH:10][C:9]2[C:8]([NH:12][C:13]3[CH:18]=[CH:17][CH:16]=[C:15]([Br:19])[CH:14]=3)=[N:7][CH:6]=[N:5][C:4]=2[CH:3]=1.[C:20](OC(=O)C)(=[O:22])[CH3:21].C(N(CC)CC)C', 'CN(C1C=CN=CC=1)C', '[C:20]([NH:1][C:2]1[N:11]=[CH:10][C:9]2[C:8]([NH:12][C:13]3[CH:18]=[CH:17][CH:16]=[C:15]([Br:19])[CH:14]=3)=[N:7][CH:6]=[N:5][C:4]=2[CH:3]=1)(=[O:22])[CH3:21]']","['US20010027197A1', '0363', 'A mixture of 7-amino-4-(3-bromoanilino)pyrido[4,3-d]pyrimidine (0.154 g, 0.49 mmol), acetic anhydride (0.14 mL, 1.5 mmol), triethylamine (0.14 mL, 1.0 mmol) and a catalytic amount of 4-(N,N-dimethylamino)pyridine are stirred under N2 at room temperature for 18 h. The reaction is then quenched by addition of ice water. The dark precipitate is collected by Buchner filtration and is purified by preparative tlc (Rf=0.25, 7% MeOH/CHCl3). Recrystallization from EtOH gives 7-acetylamino-4-(3-bromoanilino)pyrido[4,3-d]-pyrimidine (13.5 mg, 7.7%). 1H NMR (DMSO) δ 10.92 (1H, s), 10.22 (1H, s), 9.64 (1H, s), 8.70 (1H, s), 8.28 (1H, s), 8.21 (1H,s), 7.88 (1H, d, J=7.7Hz) 7.41-7.34 (3H, m), 2.16 (3H, s).']","[{'chemical_names': ['7-amino-4-(3-bromoanilino)pyrido[4,3-d]pyrimidine'], 'identifiers': ['smiles:Nc1cc2ncnc(Nc3cccc(Br)c3)c2cn1', 'inchi:InChI=1S/C13H10BrN5/c14-8-2-1-3-9(4-8)19-13-10-6-16-12(15)5-11(10)17-7-18-13/h1-7H,(H2,15,16)(H,17,18,19)'], 'amounts': ['0.49 mmol', '0.154 g'], 'appearances': []}, {'chemical_names': ['acetic anhydride'], 'identifiers': ['smiles:CC(=O)OC(C)=O', 'inchi:InChI=1S/C4H6O3/c1-3(5)7-4(2)6/h1-2H3'], 'amounts': ['1.5 mmol', '0.14 mL'], 'appearances': []}, {'chemical_names': ['triethylamine'], 'identifiers': ['smiles:CCN(CC)CC', 'inchi:InChI=1S/C6H15N/c1-4-7(5-2)6-3/h4-6H2,1-3H3'], 'amounts': ['1.0 mmol', '0.14 mL'], 'appearances': []}]","[{'chemical_names': ['7-acetylamino-4-(3-bromoanilino)pyrido[4,3-d]-pyrimidine'], 'identifiers': ['smiles:CC(=O)Nc1cc2ncnc(Nc3cccc(Br)c3)c2cn1', 'inchi:InChI=1S/C15H12BrN5O/c1-9(22)20-14-6-13-12(7-17-14)15(19-8-18-13)21-11-4-2-3-10(16)5-11/h2-8H,1H3,(H,17,20,22)(H,18,19,21)'], 'amounts': ['13.5 mg', '7.7%', '7.7'], 'appearances': []}]",[],"[{'chemical_names': ['4-(N,N-dimethylamino)pyridine'], 'identifiers': ['smiles:CN(C)c1ccncc1', 'inchi:InChI=1S/C7H10N2/c1-9(2)7-3-5-8-6-4-7/h3-6H,1-2H3'], 'amounts': [], 'appearances': []}]","['step 1:A mixture of 7-amino-4-(3-bromoanilino)pyrido[4,3-d]pyrimidine (0.154 g, 0.49 mmol), acetic anhydride (0.14 mL, 1.5 mmol), triethylamine (0.14 mL, 1.0 mmol)', 'step 2:a catalytic amount of 4-(N,N-dimethylamino)pyridine are stirred under N2 at room temperature for 18 h', 'step 2 properties:Time:64800', 'step 2 properties:Temperature:room temperature', 'step 3:The reaction is then quenched by addition of ice water', 'step 4:The dark precipitate is collected by Buchner filtration', 'step 5:is purified by preparative tlc (Rf=0.25, 7% MeOH/CHCl3)', 'step 6:Recrystallization from EtOH', 'step 7:gives 7-acetylamino-4-(3-bromoanilino)pyrido[4,3-d]-pyrimidine (13.5 mg, 7.7%)']"
"['[C:1](Cl)(=[O:3])[CH3:2].[NH2:5][C:6]1[N:15]=[CH:14][C:13]2[C:12]([S:16][CH3:17])=[N:11][CH:10]=[N:9][C:8]=2[CH:7]=1.CCN(CC)CC.O', 'C1COCC1', '[C:1]([NH:5][C:6]1[N:15]=[CH:14][C:13]2[C:12]([S:16][CH3:17])=[N:11][CH:10]=[N:9][C:8]=2[CH:7]=1)(=[O:3])[CH3:2]']","['US20010027197A1', '0381', 'Acetyl chloride (0.70 mL, 9.84 mmol) is added to a solution of 7-amino-4-methylthiopyrido[4,3-d]pyrimidine (0.20 g, 1.04 mmol) (described in a previous experimental) and Et3N (1.51 mL, 10.8 mmol) in THF at 0° C., and then the mixture is stirred at 20° C. for 4 h. Water (50 mL) was added, then the solution was extracted with EtOAc (3×50 mL). Evaporation and chromatography on alumina (18 EtOH/CHCl3) yields 7-acetylamino-4-methylthiopyrido[4,3-d]pyrimidine (0.12 g, 49%) as a yellow solid,. 1H NMR (DMSO) δ 11.05 ( 1H, s), 9.30 (1H, s), 9.02 (1H, s), 8.38 (1H, s), 2.71 (3H, s) , 2.18 (3H, s)']","[{'chemical_names': ['Acetyl chloride'], 'identifiers': ['smiles:CC(=O)Cl', 'inchi:InChI=1S/C2H3ClO/c1-2(3)4/h1H3'], 'amounts': ['9.84 mmol', '0.70 mL'], 'appearances': []}, {'chemical_names': ['7-amino-4-methylthiopyrido[4,3-d]pyrimidine'], 'identifiers': ['smiles:CSc1ncnc2cc(N)ncc12', 'inchi:InChI=1S/C8H8N4S/c1-13-8-5-3-10-7(9)2-6(5)11-4-12-8/h2-4H,1H3,(H2,9,10)'], 'amounts': ['1.04 mmol', '0.20 g'], 'appearances': []}, {'chemical_names': ['Et3N'], 'identifiers': ['smiles:CCN(CC)CC', 'inchi:InChI=1S/C6H15N/c1-4-7(5-2)6-3/h4-6H2,1-3H3'], 'amounts': ['10.8 mmol', '1.51 mL'], 'appearances': []}, {'chemical_names': ['Water'], 'identifiers': ['smiles:O', 'inchi:InChI=1S/H2O/h1H2'], 'amounts': ['50 mL'], 'appearances': []}]","[{'chemical_names': ['7-acetylamino-4-methylthiopyrido[4,3-d]pyrimidine'], 'identifiers': ['smiles:CSc1ncnc2cc(NC(C)=O)ncc12', 'inchi:InChI=1S/C10H10N4OS/c1-6(15)14-9-3-8-7(4-11-9)10(16-2)13-5-12-8/h3-5H,1-2H3,(H,11,14,15)'], 'amounts': ['0.12 g', '49%', '49.3'], 'appearances': ['yellow']}]","[{'chemical_names': ['THF'], 'identifiers': ['smiles:C1CCOC1', 'inchi:InChI=1S/C4H8O/c1-2-4-5-3-1/h1-4H2'], 'amounts': [], 'appearances': []}]",[],"['step 1:Acetyl chloride (0.70 mL, 9.84 mmol) is added to a solution of 7-amino-4-methylthiopyrido[4,3-d]pyrimidine (0.20 g, 1.04 mmol) (', 'step 2:at 0° C.', 'step 2 properties:Temperature:0', 'step 3:the mixture is stirred at 20° C. for 4 h', 'step 3 properties:Time:14400', 'step 3 properties:Temperature:20', 'step 4:Water (50 mL) was added', 'step 5:the solution was extracted with EtOAc (3×50 mL)', 'step 6:Evaporation and chromatography on alumina (18 EtOH/CHCl3)', 'step 7:yields 7-acetylamino-4-methylthiopyrido[4,3-d]pyrimidine (0.12 g, 49%) as a yellow solid']"
"['[NH2:1][C:2]1[CH:3]=[CH:4][C:5]([Cl:8])=[N:6][CH:7]=1.[C:9]([O:13][C:14](O[C:14]([O:13][C:9]([CH3:12])([CH3:11])[CH3:10])=[O:15])=[O:15])([CH3:12])([CH3:11])[CH3:10].CCN(CC)CC', 'C(Cl)Cl', '[C:9]([O:13][C:14]([NH:1][C:2]1[CH:3]=[CH:4][C:5]([Cl:8])=[N:6][CH:7]=1)=[O:15])([CH3:12])([CH3:11])[CH3:10]']","['US20010027197A1', '0396', 'A mixture of 5-amino-2-chloropyridine (12.86 g, 0.1 mol), di-tert-butyldicarbonate (24.0 g, 0.11 mol) and Et3N (12.1 g, 1.12 mol) in CH2Cl2 (150 mL) is heated under reflux for 12 h, cooled, and the precipitate is filtered off. The organic layer is washed with water, dried (CaCl2) and filtered through a short column of alumina. Removal of the solvent gives 5-[N-(tert-butoxycarbonyl)amino]-2-chloropyridine (11.9 g, 52%). 1H NMR (CDCl3) δ 8.31 (1H, d, J=2.9 Hz), 7.94 (1H, dd, J=8.6, 2.6 Hz), 7.24 (1H, d, J=8.7 Hz), 7.15 (1H, m), 1.51 (9 H, s).']","[{'chemical_names': ['5-amino-2-chloropyridine'], 'identifiers': ['smiles:Nc1ccc(Cl)nc1', 'inchi:InChI=1S/C5H5ClN2/c6-5-2-1-4(7)3-8-5/h1-3H,7H2'], 'amounts': ['0.1 mol', '12.86 g'], 'appearances': []}, {'chemical_names': ['di-tert-butyldicarbonate'], 'identifiers': ['smiles:CC(C)(C)OC(=O)OC(=O)OC(C)(C)C', 'inchi:InChI=1S/C10H18O5/c1-9(2,3)14-7(11)13-8(12)15-10(4,5)6/h1-6H3'], 'amounts': ['0.11 mol', '24.0 g'], 'appearances': []}, {'chemical_names': ['Et3N'], 'identifiers': ['smiles:CCN(CC)CC', 'inchi:InChI=1S/C6H15N/c1-4-7(5-2)6-3/h4-6H2,1-3H3'], 'amounts': ['1.12 mol', '12.1 g'], 'appearances': []}]","[{'chemical_names': ['5-[N-(tert-butoxycarbonyl)amino]-2-chloropyridine'], 'identifiers': ['smiles:CC(C)(C)OC(=O)Nc1ccc(Cl)nc1', 'inchi:InChI=1S/C10H13ClN2O2/c1-10(2,3)15-9(14)13-7-4-5-8(11)12-6-7/h4-6H,1-3H3,(H,13,14)'], 'amounts': ['11.9 g', '52%', '52.0'], 'appearances': []}]","[{'chemical_names': ['CH2Cl2'], 'identifiers': ['smiles:ClCCl', 'inchi:InChI=1S/CH2Cl2/c2-1-3/h1H2'], 'amounts': ['150 mL'], 'appearances': []}]",[],"['step 1:A mixture of 5-amino-2-chloropyridine (12.86 g, 0.1 mol), di-tert-butyldicarbonate (24.0 g, 0.11 mol) and Et3N (12.1 g, 1.12 mol) in CH2Cl2 (150 mL)', 'step 2:is heated', 'step 3:under reflux for 12 h', 'step 3 properties:Time:43200', 'step 4:cooled', 'step 5:the precipitate is filtered off', 'step 6:The organic layer is washed with water', 'step 7:dried (CaCl2)', 'step 8:filtered through a short column of alumina', 'step 9:Removal of the solvent', 'step 10:gives 5-[N-(tert-butoxycarbonyl)amino]-2-chloropyridine (11.9 g, 52%)']"
"['[Br:1][C:2]1[CH:3]=[C:4]([CH:17]=[CH:18][CH:19]=1)[NH:5][C:6]1[C:7]2[CH:15]=[CH:14][C:13](F)=[N:12][C:8]=2[N:9]=[CH:10][N:11]=1.Cl.[CH3:21][NH:22][CH3:23].CCN(CC)CC', 'CCO', '[Br:1][C:2]1[CH:3]=[C:4]([CH:17]=[CH:18][CH:19]=1)[NH:5][C:6]1[C:7]2[CH:15]=[CH:14][C:13]([N:22]([CH3:23])[CH3:21])=[N:12][C:8]=2[N:9]=[CH:10][N:11]=1 |f:1.2|']","['US20010027197A1', '0418', 'Reaction of 4-(3-bromoanilino)-7-fluoropyrido[2,3-d]pyrimidine (see a previous experimental) (0.12 g, 0.38 mmol) with dimethylamine hydrochloride (92 mg, 1.13 mmol) and Et3N (0.18 mL, 1.32 mmol) in EtOH (15 mL) at 100° C. for 18 h in a pressure vessel, followed by evaporation of the solvent and workup, gives 4-(3-bromoanilino)-7-(dimethylamino)pyrido[2,3-d]pyrimidine (0.11 g, 84%). 1H NMR (DMSO) δ 9.58 (1H, brs), 8.56 (1H, d, J=9.3 Hz), 8.54 (1H, s), 8.18 (1H, t, J=1.9 Hz), 7.84 (dt, Jd=8.0, Hz, J5=1.9 Hz), 7.33 (1H, dd, J=8.1, 8.0 Hz) 7.25 (1H, dt, Jd=9-3, Hz, Jt=1.9 Hz), 7.10 (1H, d, J=9.3 Hz), 3.18 (6H, s).']","[{'chemical_names': ['4-(3-bromoanilino)-7-fluoropyrido[2,3-d]pyrimidine'], 'identifiers': ['smiles:Fc1ccc2c(Nc3cccc(Br)c3)ncnc2n1', 'inchi:InChI=1S/C13H8BrFN4/c14-8-2-1-3-9(6-8)18-12-10-4-5-11(15)19-13(10)17-7-16-12/h1-7H,(H,16,17,18,19)'], 'amounts': [], 'appearances': []}, {'chemical_names': ['dimethylamine hydrochloride'], 'identifiers': ['smiles:CNC.Cl', 'inchi:InChI=1S/C2H7N.ClH/c1-3-2;/h3H,1-2H3;1H'], 'amounts': ['1.13 mmol', '92 mg'], 'appearances': []}, {'chemical_names': ['Et3N'], 'identifiers': ['smiles:CCN(CC)CC', 'inchi:InChI=1S/C6H15N/c1-4-7(5-2)6-3/h4-6H2,1-3H3'], 'amounts': ['1.32 mmol', '0.18 mL'], 'appearances': []}]","[{'chemical_names': ['4-(3-bromoanilino)-7-(dimethylamino)pyrido[2,3-d]pyrimidine'], 'identifiers': ['smiles:CN(C)c1ccc2c(Nc3cccc(Br)c3)ncnc2n1', 'inchi:InChI=1S/C15H14BrN5/c1-21(2)13-7-6-12-14(17-9-18-15(12)20-13)19-11-5-3-4-10(16)8-11/h3-9H,1-2H3,(H,17,18,19,20)'], 'amounts': ['0.11 g', '84%'], 'appearances': []}]","[{'chemical_names': ['EtOH'], 'identifiers': ['smiles:CCO', 'inchi:InChI=1S/C2H6O/c1-2-3/h3H,2H2,1H3'], 'amounts': ['15 mL'], 'appearances': []}]",[],"['step 1:Reaction of 4-(3-bromoanilino)-7-fluoropyrido[2,3-d]pyrimidine (', 'step 2:at 100° C.', 'step 2 properties:Temperature:100', 'step 3:for 18 h', 'step 3 properties:Time:64800', 'step 4:followed by evaporation of the solvent and workup', 'step 5:gives 4-(3-bromoanilino)-7-(dimethylamino)pyrido[2,3-d]pyrimidine (0.11 g, 84%)']"
"['[C:1]([CH2:3][C:4]([O:6][CH3:7])=[O:5])#[N:2].[S:8]1CC(O)S[CH2:10][CH:9]1O.C(N(CC)CC)C', 'CCO', '[NH2:2][C:1]1[S:8][CH:9]=[CH:10][C:3]=1[C:4]([O:6][CH3:7])=[O:5]']","['US20010027197A1', '0433', 'A mixture of methyl cyanoacetate (3.25 g, 32.3 mmol), 1,4 dithiane-2,5 diol (5 g, 32.8 mmol), triethylamine (1 mL, 7.71 mmol) in EtOH (50 mL) is stirred at 40° C. for 1 h. The cooled solution is eluted through a silica plug with CH2Cl2 . The filtrate is stripped to dryness to give crude methyl 2-aminothiophene-3-carboxylate which is carried on to the next reaction. 1H NMR (DMSO) δ 7.26 (1H, s), 6.82 (1H, d, J=5.8 Hz), 6.28 (1H, d, J=5.8 Hz), 3.69 (3H, s).']","[{'chemical_names': ['methyl cyanoacetate'], 'identifiers': ['smiles:COC(=O)CC#N', 'inchi:InChI=1S/C4H5NO2/c1-7-4(6)2-3-5/h2H2,1H3'], 'amounts': ['32.3 mmol', '3.25 g'], 'appearances': []}, {'chemical_names': ['1,4 dithiane-2,5 diol'], 'identifiers': ['smiles:OC1CSC(O)CS1', 'inchi:InChI=1S/C4H8O2S2/c5-3-1-7-4(6)2-8-3/h3-6H,1-2H2'], 'amounts': ['32.8 mmol', '5 g'], 'appearances': []}, {'chemical_names': ['triethylamine'], 'identifiers': ['smiles:CCN(CC)CC', 'inchi:InChI=1S/C6H15N/c1-4-7(5-2)6-3/h4-6H2,1-3H3'], 'amounts': ['7.71 mmol', '1 mL'], 'appearances': []}]","[{'chemical_names': ['methyl 2-aminothiophene-3-carboxylate'], 'identifiers': ['smiles:COC(=O)c1ccsc1N', 'inchi:InChI=1S/C6H7NO2S/c1-9-6(8)4-2-3-10-5(4)7/h2-3H,7H2,1H3'], 'amounts': [], 'appearances': []}]","[{'chemical_names': ['EtOH'], 'identifiers': ['smiles:CCO', 'inchi:InChI=1S/C2H6O/c1-2-3/h3H,2H2,1H3'], 'amounts': ['50 mL'], 'appearances': []}]",[],"['step 1:A mixture of methyl cyanoacetate (3.25 g, 32.3 mmol), 1,4 dithiane-2,5 diol (5 g, 32.8 mmol), triethylamine (1 mL, 7.71 mmol) in EtOH (50 mL)', 'step 2:is stirred at 40° C. for 1 h', 'step 2 properties:Time:3600', 'step 2 properties:Temperature:40', 'step 3:The cooled solution is eluted through a silica plug with CH2Cl2', 'step 4:to give crude methyl 2-aminothiophene-3-carboxylate which']"
"['CS(C)=O.C(Cl)(=O)C(Cl)=O.[Cl:11][C:12]1[CH:17]=[CH:16][C:15]([C@@H:18]([C:24]2[CH:29]=[CH:28][C:27]([C:30]([O:32][CH3:33])=[O:31])=[CH:26][CH:25]=2)[N:19]2[CH2:22][CH:21]([OH:23])[CH2:20]2)=[CH:14][CH:13]=1.C(N(CC)CC)C', 'ClCCl.O', '[Cl:11][C:12]1[CH:17]=[CH:16][C:15]([C@@H:18]([C:24]2[CH:29]=[CH:28][C:27]([C:30]([O:32][CH3:33])=[O:31])=[CH:26][CH:25]=2)[N:19]2[CH2:20][C:21](=[O:23])[CH2:22]2)=[CH:14][CH:13]=1']","['US20010027193A1', '0291', '1-{(R*)-(4-Chlorophenyl)[4-methoxycarbonyl)-phenyl]methyl}azetidin-3-one, A isomer form, may be prepared by carrying out the procedure in the following manner: 0.90 cm3 of dimethyl sulfoxide is poured over 10 minutes into a solution, cooled to −60° C., of 0.55 cm3 of oxalyl chloride in 5 cm3 of dichloromethane. After stirring for 30 minutes at −60° C., a solution of 1.75 g of 1-{(R*)-(4-chlorophenyl)[4-(methoxycarbonyl)-phenyl]methyl}azetidin-3-ol, A isomer form, in 20 cm3 of dichloromethane is added to the mixture over 15 minutes. After stirring for 3 hours at −60° C., 2.7 cm3 of triethylamine are poured in and then the reaction medium is allowed to return to 0° C. 20 cm3 of water are then added, the mixture is stirred and then separated after settling. The organic phase is dried over magnesium sulfate, filtered and then concentrated to dryness at 50° C. under reduced pressure (2.7 kPa). The orange-colored oil obtained is chromatographed on a silica gel column (particle size 0.06-0.200 mm, diameter 2 cm, height 30 cm), under an argon pressure of 0.5 bar, eluting with a cyclohexane and ethyl acetate (75/25 by volume) mixture and collecting 30-cm3 fractions. Fractions 2 to 15 are combined and then concentrated to dryness under reduced pressure (2.7 kPa). 1.45 g of 1-{(R*)-(4-chlorophenyl)[4-(methoxycarbonyl)phenyl]methyl}azetidin-3-one, A isomer form, are obtained in the form of a yellow foam.']","[{'chemical_names': ['dimethyl sulfoxide'], 'identifiers': ['smiles:CS(C)=O', 'inchi:InChI=1S/C2H6OS/c1-4(2)3/h1-2H3'], 'amounts': ['0.90 cm3'], 'appearances': []}, {'chemical_names': ['oxalyl chloride'], 'identifiers': ['smiles:O=C(Cl)C(=O)Cl', 'inchi:InChI=1S/C2Cl2O2/c3-1(5)2(4)6'], 'amounts': ['0.55 cm3'], 'appearances': []}, {'chemical_names': ['1-{(R*)-(4-chlorophenyl)[4-(methoxycarbonyl)-phenyl]methyl}azetidin-3-ol'], 'identifiers': ['smiles:COC(=O)c1ccc([C@H](c2ccc(Cl)cc2)N2CC(O)C2)cc1', 'inchi:InChI=1S/C18H18ClNO3/c1-23-18(22)14-4-2-12(3-5-14)17(20-10-16(21)11-20)13-6-8-15(19)9-7-13/h2-9,16-17,21H,10-11H2,1H3/t17-/m1/s1'], 'amounts': ['1.75 g'], 'appearances': []}, {'chemical_names': ['triethylamine'], 'identifiers': ['smiles:CCN(CC)CC', 'inchi:InChI=1S/C6H15N/c1-4-7(5-2)6-3/h4-6H2,1-3H3'], 'amounts': ['2.7 cm3'], 'appearances': []}]","[{'chemical_names': ['1-{(R*)-(4-chlorophenyl)[4-(methoxycarbonyl)phenyl]methyl}azetidin-3-one'], 'identifiers': ['smiles:COC(=O)c1ccc([C@H](c2ccc(Cl)cc2)N2CC(=O)C2)cc1', 'inchi:InChI=1S/C18H16ClNO3/c1-23-18(22)14-4-2-12(3-5-14)17(20-10-16(21)11-20)13-6-8-15(19)9-7-13/h2-9,17H,10-11H2,1H3/t17-/m1/s1'], 'amounts': ['1.45 g', '83.4'], 'appearances': []}]","[{'chemical_names': ['dichloromethane'], 'identifiers': ['smiles:ClCCl', 'inchi:InChI=1S/CH2Cl2/c2-1-3/h1H2'], 'amounts': ['5 cm3'], 'appearances': []}, {'chemical_names': ['dichloromethane'], 'identifiers': ['smiles:ClCCl', 'inchi:InChI=1S/CH2Cl2/c2-1-3/h1H2'], 'amounts': ['20 cm3'], 'appearances': []}, {'chemical_names': ['water'], 'identifiers': ['smiles:O', 'inchi:InChI=1S/H2O/h1H2'], 'amounts': ['20 cm3'], 'appearances': []}]",[],"['step 1:1-{(R*)-(4-Chlorophenyl)[4-methoxycarbonyl)-phenyl]methyl}azetidin-3-one, A isomer form, may be prepared', 'step 2:0.90 cm3 of dimethyl sulfoxide is poured over 10 minutes into a solution', 'step 2 properties:Time:600', 'step 3:cooled to −60° C., of 0.55 cm3 of oxalyl chloride in 5 cm3 of dichloromethane', 'step 3 properties:Temperature:-60', 'step 4:After stirring for 30 minutes at −60° C.', 'step 4 properties:Time:1800', 'step 4 properties:Temperature:-60', 'step 5:a solution of 1.75 g of 1-{(R*)-(4-chlorophenyl)[4-(methoxycarbonyl)-phenyl]methyl}azetidin-3-ol, A isomer form, in 20 cm3 of dichloromethane is added to the mixture over 15 minutes', 'step 5 properties:Time:900', 'step 6:After stirring for 3 hours at −60° C.', 'step 6 properties:Time:10800', 'step 6 properties:Temperature:-60', 'step 7:2.7 cm3 of triethylamine are poured in and then the reaction medium', 'step 8:to return to 0° C', 'step 8 properties:Temperature:0', 'step 9:20 cm3 of water are then added', 'step 10:the mixture is stirred', 'step 11:separated', 'step 12:The organic phase is dried over magnesium sulfate', 'step 13:filtered', 'step 14:concentrated to dryness at 50° C. under reduced pressure (2.7 kPa)', 'step 14 properties:Temperature:50', 'step 14 properties:Pressure:reduced pressure', 'step 14 properties:Pressure:2700', 'step 15:The orange-colored oil obtained', 'step 16:is chromatographed on a silica gel column (particle size 0.06-0.200 mm, diameter 2 cm, height 30 cm), under an argon pressure of 0.5 bar', 'step 16 properties:Pressure:50000', 'step 17:eluting with a cyclohexane and ethyl acetate (75/25 by volume) mixture', 'step 18:collecting 30-cm3 fractions', 'step 19:concentrated to dryness under reduced pressure (2.7 kPa)', 'step 19 properties:Pressure:reduced pressure', 'step 19 properties:Pressure:2700', 'step 20:1.45 g of 1-{(R*)-(4-chlorophenyl)[4-(methoxycarbonyl)phenyl]methyl}azetidin-3-one, A isomer form, are obtained in the form of a yellow foam']"
"['[NH2:1][CH2:2][CH2:3][N:4]1[CH2:8][CH2:7][CH2:6][CH2:5]1.Cl.CN(C)CCCN=C=NCC.O.OC1C2N=NNC=2C=CC=1.Cl.[Cl:33][C:34]1[CH:39]=[CH:38][C:37]([CH:40]([C:57]2[CH:62]=[CH:61][C:60]([Cl:63])=[CH:59][CH:58]=2)[N:41]2[CH2:44][CH:43]([CH:45]([C:49]3[CH:54]=[C:53]([F:55])[CH:52]=[C:51]([F:56])[CH:50]=3)[C:46](O)=[O:47])[CH2:42]2)=[CH:36][CH:35]=1', 'ClCCl.C(N(CC)CC)C', '[Cl:63][C:60]1[CH:61]=[CH:62][C:57]([CH:40]([C:37]2[CH:36]=[CH:35][C:34]([Cl:33])=[CH:39][CH:38]=2)[N:41]2[CH2:44][CH:43]([CH:45]([C:49]3[CH:54]=[C:53]([F:55])[CH:52]=[C:51]([F:56])[CH:50]=3)[C:46]([NH:1][CH2:2][CH2:3][N:4]3[CH2:8][CH2:7][CH2:6][CH2:5]3)=[O:47])[CH2:42]2)=[CH:58][CH:59]=1 |f:1.2,3.4,5.6|']","['US20010027193A1', '0445', '(RS)-2-{1-[[Bis(4-chlorophenyl)methyl]-azetidin-3-yl}-2-(3,5-difluorophenyl)-N-(2-pyrrolidin-1-ylethyl)acetamide may be prepared in the following manner: 0.015 cm3 of aminoethylpyrrolidine, 29 mg of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride, 0.028 cm3 of triethylamine and 1.5 mg of hydroxybenzotriazole hydrate are successively added to a solution of 50 mg of (RS)-{1-[bis(4-chlorophenyl)-methyl]azetidin-3-yl}-(3,5-difluorophenyl)acetic acid hydrochloride in 2 cm3 of anhydrous dichloromethane, at a temperature in the region of 20° C. The solution obtained is stirred at a temperature in the region of 20° C. for about 12 hours. The reaction medium is deposited on a Varian cartridge (6 cm3) filled with 3 g of fine silica (0.040-0.063 mm), conditioned with dichloromethane with the aid of a Duramat pump, eluted with a dichloromethane-ethanol (98-04 by volume) mixture, collecting 1.5-cm3 fractions. Fractions 13 to 20 are combined and concentrated to dryness under reduced pressure (2.7 kPa) at 40° C. 33 mg of (RS)-2-{1-[bis(4-chlorophenyl)methyl]azetidin-3-yl}-2-(3,5-difluorophenyl)-N-(2-pyrrolidin-1-ylethyl)acetamide are thus obtained in the form of a white foam [1H NMR spectrum (300 MHz, CDCl3, δ in ppm) 1.78 (mt: 4H); from 2.50 to 2.70 (mt: 3H); 2.54 (mt: 4H); 2.91 (dd, J=7.5 and 5 Hz: 1H); 3.10 (mt: 2H); from 3.20 to 3.45 (mt: 3H); 3.64 (d, J=10.5 Hz: 1H); 4.27 (s: 1H); 6.67 (tt, J=9 and 2.5 Hz: 1H); 6.86 (mt: 2H); from 7.15 to 7.35 (mt: 8H)].']","[{'chemical_names': ['1-[[Bis(4-chlorophenyl)methyl]-azetidin-3-yl}-2-(3,5-difluorophenyl)-N-(2-pyrrolidin-1-ylethyl)acetamide'], 'identifiers': [], 'amounts': [], 'appearances': []}, {'chemical_names': ['aminoethylpyrrolidine'], 'identifiers': ['smiles:NCCN1CCCC1', 'inchi:InChI=1S/C6H14N2/c7-3-6-8-4-1-2-5-8/h1-7H2'], 'amounts': ['0.015 cm3'], 'appearances': []}, {'chemical_names': ['1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride'], 'identifiers': ['smiles:CCN=C=NCCCN(C)C.Cl', 'inchi:InChI=1S/C8H17N3.ClH/c1-4-9-8-10-6-5-7-11(2)3;/h4-7H2,1-3H3;1H'], 'amounts': ['29 mg'], 'appearances': []}, {'chemical_names': ['hydroxybenzotriazole hydrate'], 'identifiers': ['smiles:O.Oc1cccc2[nH]nnc12', 'inchi:InChI=1S/C6H5N3O.H2O/c10-5-3-1-2-4-6(5)8-9-7-4;/h1-3,10H,(H,7,8,9);1H2'], 'amounts': ['1.5 mg'], 'appearances': []}, {'chemical_names': ['(RS)-{1-[bis(4-chlorophenyl)-methyl]azetidin-3-yl}-(3,5-difluorophenyl)acetic acid hydrochloride'], 'identifiers': ['smiles:Cl.O=C(O)C(c1cc(F)cc(F)c1)C1CN(C(c2ccc(Cl)cc2)c2ccc(Cl)cc2)C1', 'inchi:InChI=1S/C24H19Cl2F2NO2.ClH/c25-18-5-1-14(2-6-18)23(15-3-7-19(26)8-4-15)29-12-17(13-29)22(24(30)31)16-9-20(27)11-21(28)10-16;/h1-11,17,22-23H,12-13H2,(H,30,31);1H'], 'amounts': ['50 mg'], 'appearances': []}]","[{'chemical_names': ['(RS)-2-{1-[bis(4-chlorophenyl)methyl]azetidin-3-yl}-2-(3,5-difluorophenyl)-N-(2-pyrrolidin-1-ylethyl)acetamide'], 'identifiers': ['smiles:O=C(NCCN1CCCC1)C(c1cc(F)cc(F)c1)C1CN(C(c2ccc(Cl)cc2)c2ccc(Cl)cc2)C1', 'inchi:InChI=1S/C30H31Cl2F2N3O/c31-24-7-3-20(4-8-24)29(21-5-9-25(32)10-6-21)37-18-23(19-37)28(22-15-26(33)17-27(34)16-22)30(38)35-11-14-36-12-1-2-13-36/h3-10,15-17,23,28-29H,1-2,11-14,18-19H2,(H,35,38)'], 'amounts': ['33 mg'], 'appearances': []}]","[{'chemical_names': ['dichloromethane'], 'identifiers': ['smiles:ClCCl', 'inchi:InChI=1S/CH2Cl2/c2-1-3/h1H2'], 'amounts': ['2 cm3'], 'appearances': []}, {'chemical_names': ['dichloromethane'], 'identifiers': ['smiles:ClCCl', 'inchi:InChI=1S/CH2Cl2/c2-1-3/h1H2'], 'amounts': [], 'appearances': []}, {'chemical_names': ['triethylamine'], 'identifiers': ['smiles:CCN(CC)CC', 'inchi:InChI=1S/C6H15N/c1-4-7(5-2)6-3/h4-6H2,1-3H3'], 'amounts': ['0.028 cm3'], 'appearances': []}]",[],"['step 1:(RS)-2-{1-[[Bis(4-chlorophenyl)methyl]-azetidin-3-yl}-2-(3,5-difluorophenyl)-N-(2-pyrrolidin-1-ylethyl)acetamide may be prepared in the following manner', 'step 2:0.015 cm3 of aminoethylpyrrolidine, 29 mg of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride, 0.028 cm3 of triethylamine and 1.5 mg of hydroxybenzotriazole hydrate are successively added to a solution of 50 mg of (RS)-{1-[bis(4-chlorophenyl)-methyl]azetidin-3-yl}-(3,5-difluorophenyl)acetic acid hydrochloride in 2 cm3 of anhydrous dichloromethane, at a temperature in the region of 20° C', 'step 2 properties:Temperature:20', 'step 3:The solution obtained', 'step 4:is stirred at a temperature in the region of 20° C. for about 12 hours', 'step 4 properties:Time:~43200', 'step 4 properties:Temperature:20', 'step 5:filled with 3 g of fine silica (0.040-0.063 mm)', 'step 6:eluted with a dichloromethane-ethanol (98-04 by volume) mixture', 'step 7:collecting 1.5-cm3 fractions', 'step 8:concentrated to dryness under reduced pressure (2.7 kPa) at 40° C', 'step 8 properties:Temperature:40', 'step 8 properties:Pressure:reduced pressure', 'step 8 properties:Pressure:2700', 'step 9:33 mg of (RS)-2-{1-[bis(4-chlorophenyl)methyl]azetidin-3-yl}-2-(3,5-difluorophenyl)-N-(2-pyrrolidin-1-ylethyl)acetamide are thus obtained in the form of a white foam [1H NMR spectrum (300 MHz, CDCl3, δ in ppm) 1.78 (mt: 4H); from 2.50 to 2.70 (mt: 3H); 2.54 (mt: 4H); 2.91 (dd, J=7.5 and 5 Hz: 1H); 3.10 (mt: 2H); from 3.20 to 3.45 (mt: 3H); 3.64 (d, J=10.5 Hz: 1H); 4.27 (s: 1H); 6.67 (tt, J=9 and 2.5 Hz: 1H); 6.86 (mt: 2H); from 7.15 to 7.35 (mt: 8H)]']"
"['CN.Cl.[CH3:4][N:5](C)CCCN=C=NCC.O.OC1C2N=NNC=2C=CC=1.Cl.[Cl:27][C:28]1[CH:33]=[CH:32][C:31]([CH:34]([C:51]2[CH:56]=[CH:55][C:54]([Cl:57])=[CH:53][CH:52]=2)[N:35]2[CH2:38][CH:37]([CH:39]([C:43]3[CH:48]=[C:47]([F:49])[CH:46]=[C:45]([F:50])[CH:44]=3)[C:40](O)=[O:41])[CH2:36]2)=[CH:30][CH:29]=1', 'O1CCCC1.ClCCl.C(N(CC)CC)C', '[Cl:27][C:28]1[CH:33]=[CH:32][C:31]([CH:34]([C:51]2[CH:56]=[CH:55][C:54]([Cl:57])=[CH:53][CH:52]=2)[N:35]2[CH2:38][CH:37]([CH:39]([C:43]3[CH:48]=[C:47]([F:49])[CH:46]=[C:45]([F:50])[CH:44]=3)[C:40]([NH:5][CH3:4])=[O:41])[CH2:36]2)=[CH:30][CH:29]=1 |f:1.2,3.4,5.6|']","['US20010027193A1', '0448', '(RS)-2-{1-[[Bis(4-chlorophenyl)methyl]-azetidin-3-yl}-2-(3,5-difluorophenyl)-N-propylacetamide may be prepared in the following manner: 0.050 cm3 of a 2 M solution of methylamine in tetrahydrofuran, 29 mg of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride, 0.028 cm3 of triethylamine and 1.5 mg of hydroxybenzotriazole hydrate are successively added to a solution of 50 mg of (RS)-{1-[bis(4-chlorophenyl)-methyl]azetidin-3-yl}-(3,5-difluorophenyl)acetic acid hydrochloride in 2 cm3 of anhydrous dichloromethane, at a temperature in the region of 20° C. The solution obtained is stirred at a temperature in the region of 20° C. for about 12 hours. The reaction medium is deposited on a Varian cartridge (6 cm3) filled with 3 g of fine silica (0.040-0.063 mm) conditioned and eluted with dichloromethane with the aid of a Duramat pump. The fractions containing only the desired product are combined and concentrated to dryness under reduced pressure (2.7 kPa) at 40° C. 19 mg of (RS)-2-{1-[bis(4-chlorophenyl)methyl]azetidin-3-yl}-2-(3,5-difluorophenyl)-N-methylacetamide are thus obtained in the form of a white solid [1H NMR spectrum (300 MHz, CDCl3, δ in ppm): 2.66 (mt: 1H); 2.76 (d, J=5 Hz: 3H); 2.93 (mt: 1H); 3.10 (mt: 2H); 3.44 (broad t, J=7.5 Hz: 1H); 3.59 (d, J=10.5 Hz: 1H); 4.28 (s: 1H); 5.41 (unresolved complex: 1H); 6.71 (tt, J=9 and 2.5 Hz: 1H); 6.83 (mt: 2H); from 7.20 to 7.35 (mt: 8H)].']","[{'chemical_names': ['1-[[Bis(4-chlorophenyl)methyl]-azetidin-3-yl}-2-(3,5-difluorophenyl)-N-propylacetamide'], 'identifiers': [], 'amounts': [], 'appearances': []}, {'chemical_names': ['solution'], 'identifiers': [], 'amounts': ['2 M'], 'appearances': []}, {'chemical_names': ['methylamine'], 'identifiers': ['smiles:CN', 'inchi:InChI=1S/CH5N/c1-2/h2H2,1H3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride'], 'identifiers': ['smiles:CCN=C=NCCCN(C)C.Cl', 'inchi:InChI=1S/C8H17N3.ClH/c1-4-9-8-10-6-5-7-11(2)3;/h4-7H2,1-3H3;1H'], 'amounts': ['29 mg'], 'appearances': []}, {'chemical_names': ['hydroxybenzotriazole hydrate'], 'identifiers': ['smiles:O.Oc1cccc2[nH]nnc12', 'inchi:InChI=1S/C6H5N3O.H2O/c10-5-3-1-2-4-6(5)8-9-7-4;/h1-3,10H,(H,7,8,9);1H2'], 'amounts': ['1.5 mg'], 'appearances': []}, {'chemical_names': ['(RS)-{1-[bis(4-chlorophenyl)-methyl]azetidin-3-yl}-(3,5-difluorophenyl)acetic acid hydrochloride'], 'identifiers': ['smiles:Cl.O=C(O)C(c1cc(F)cc(F)c1)C1CN(C(c2ccc(Cl)cc2)c2ccc(Cl)cc2)C1', 'inchi:InChI=1S/C24H19Cl2F2NO2.ClH/c25-18-5-1-14(2-6-18)23(15-3-7-19(26)8-4-15)29-12-17(13-29)22(24(30)31)16-9-20(27)11-21(28)10-16;/h1-11,17,22-23H,12-13H2,(H,30,31);1H'], 'amounts': ['50 mg'], 'appearances': []}]","[{'chemical_names': ['(RS)-2-{1-[bis(4-chlorophenyl)methyl]azetidin-3-yl}-2-(3,5-difluorophenyl)-N-methylacetamide'], 'identifiers': ['smiles:CNC(=O)C(c1cc(F)cc(F)c1)C1CN(C(c2ccc(Cl)cc2)c2ccc(Cl)cc2)C1', 'inchi:InChI=1S/C25H22Cl2F2N2O/c1-30-25(32)23(17-10-21(28)12-22(29)11-17)18-13-31(14-18)24(15-2-6-19(26)7-3-15)16-4-8-20(27)9-5-16/h2-12,18,23-24H,13-14H2,1H3,(H,30,32)'], 'amounts': ['19 mg', '39.9'], 'appearances': []}]","[{'chemical_names': ['tetrahydrofuran'], 'identifiers': ['smiles:C1CCOC1', 'inchi:InChI=1S/C4H8O/c1-2-4-5-3-1/h1-4H2'], 'amounts': [], 'appearances': []}, {'chemical_names': ['dichloromethane'], 'identifiers': ['smiles:ClCCl', 'inchi:InChI=1S/CH2Cl2/c2-1-3/h1H2'], 'amounts': ['2 cm3'], 'appearances': []}, {'chemical_names': ['triethylamine'], 'identifiers': ['smiles:CCN(CC)CC', 'inchi:InChI=1S/C6H15N/c1-4-7(5-2)6-3/h4-6H2,1-3H3'], 'amounts': ['0.028 cm3'], 'appearances': []}]",[],"['step 1:(RS)-2-{1-[[Bis(4-chlorophenyl)methyl]-azetidin-3-yl}-2-(3,5-difluorophenyl)-N-propylacetamide may be prepared in the following manner', 'step 2:0.050 cm3 of a 2 M solution of methylamine in tetrahydrofuran, 29 mg of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride, 0.028 cm3 of triethylamine and 1.5 mg of hydroxybenzotriazole hydrate are successively added to a solution of 50 mg of (RS)-{1-[bis(4-chlorophenyl)-methyl]azetidin-3-yl}-(3,5-difluorophenyl)acetic acid hydrochloride in 2 cm3 of anhydrous dichloromethane, at a temperature in the region of 20° C', 'step 2 properties:Temperature:20', 'step 3:The solution obtained', 'step 4:is stirred at a temperature in the region of 20° C. for about 12 hours', 'step 4 properties:Time:~43200', 'step 4 properties:Temperature:20', 'step 5:filled with 3 g of fine silica (0.040-0.063 mm)', 'step 6:eluted with dichloromethane with the aid of a Duramat pump', 'step 7:The fractions containing only the desired product', 'step 8:concentrated to dryness under reduced pressure (2.7 kPa) at 40° C', 'step 8 properties:Temperature:40', 'step 8 properties:Pressure:reduced pressure', 'step 8 properties:Pressure:2700', 'step 9:19 mg of (RS)-2-{1-[bis(4-chlorophenyl)methyl]azetidin-3-yl}-2-(3,5-difluorophenyl)-N-methylacetamide are thus obtained in the form of a white solid [1H NMR spectrum (300 MHz, CDCl3, δ in ppm): 2.66 (mt: 1H); 2.76 (d, J=5 Hz: 3H); 2.93 (mt: 1H); 3.10 (mt: 2H); 3.44 (broad t, J=7.5 Hz: 1H); 3.59 (d, J=10.5 Hz: 1H); 4.28 (s: 1H); 5.41 (unresolved complex: 1H); 6.71 (tt, J=9 and 2.5 Hz: 1H); 6.83 (mt: 2H); from 7.20 to 7.35 (mt: 8H)]']"
"['[C:1]([C:9](=[C:12](SC)[S:13][CH3:14])[C:10]#[N:11])(=O)[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.[N+]([O-])(O)=O.[NH2:21][C:22]([NH2:24])=[NH:23].C(N(CC)CC)C.O', 'CN(C=O)C', '[NH2:24][C:22]1[N:23]=[C:12]([S:13][CH3:14])[C:9]([C:10]#[N:11])=[C:1]([C:2]2[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=2)[N:21]=1 |f:1.2|']","['US20010027196A1', '0626', 'Following the method of Rudorf and Augustin (J. Prakt. Chem. 1978, 320, 576), a solution of 15.9 g (63.9 mmol) 2-benzoyl-3,3-bis(methylthio)acrylonitrile, 9.36 g (76.7 mmol) guanidine nitrate and 22.3 ml (160 mmol) triethylamine in 200 ml DMF was heated at reflux for 6 h. The reaction mixture was then cooled to room temperature. On addition of 300 ml water, a precipitate appeared which was collected by filtration and washed with water to afford 12.7 g (86%) 2-amino-4-(methylthio)-6-phenyl-pyrimidine-5-carbonitrile as a sand-coloured solid. EI-MS m-e (%): 242 (M+, 32), 241 ([M—H]+, 100).']","[{'chemical_names': ['2-benzoyl-3,3-bis(methylthio)acrylonitrile'], 'identifiers': ['smiles:CSC(SC)=C(C#N)C(=O)c1ccccc1', 'inchi:InChI=1S/C12H11NOS2/c1-15-12(16-2)10(8-13)11(14)9-6-4-3-5-7-9/h3-7H,1-2H3'], 'amounts': ['63.9 mmol', '15.9 g'], 'appearances': []}, {'chemical_names': ['guanidine nitrate'], 'identifiers': ['smiles:N=C(N)N.O=[N+]([O-])O', 'inchi:InChI=1S/CH5N3.HNO3/c2*2-1(3)4/h(H5,2,3,4);(H,2,3,4)'], 'amounts': ['76.7 mmol', '9.36 g'], 'appearances': []}, {'chemical_names': ['triethylamine'], 'identifiers': ['smiles:CCN(CC)CC', 'inchi:InChI=1S/C6H15N/c1-4-7(5-2)6-3/h4-6H2,1-3H3'], 'amounts': ['160 mmol', '22.3 ml'], 'appearances': []}, {'chemical_names': ['water'], 'identifiers': ['smiles:O', 'inchi:InChI=1S/H2O/h1H2'], 'amounts': ['300 ml'], 'appearances': []}]","[{'chemical_names': ['2-amino-4-(methylthio)-6-phenyl-pyrimidine-5-carbonitrile'], 'identifiers': ['smiles:CSc1nc(N)nc(-c2ccccc2)c1C#N', 'inchi:InChI=1S/C12H10N4S/c1-17-11-9(7-13)10(15-12(14)16-11)8-5-3-2-4-6-8/h2-6H,1H3,(H2,14,15,16)'], 'amounts': ['12.7 g', '86%', '82.0'], 'appearances': ['sand-coloured']}]","[{'chemical_names': ['DMF'], 'identifiers': ['smiles:CN(C)C=O', 'inchi:InChI=1S/C3H7NO/c1-4(2)3-5/h3H,1-2H3'], 'amounts': ['200 ml'], 'appearances': []}]",[],"['step 1:a solution of 15.9 g (63.9 mmol) 2-benzoyl-3,3-bis(methylthio)acrylonitrile, 9.36 g (76.7 mmol) guanidine nitrate and 22.3 ml (160 mmol) triethylamine in 200 ml DMF was heated', 'step 2:at reflux for 6 h', 'step 2 properties:Time:21600', 'step 3:The reaction mixture was then cooled to room temperature', 'step 3 properties:Temperature:room temperature', 'step 4:On addition of 300 ml water', 'step 5:was collected by filtration', 'step 6:washed with water', 'step 7:to afford 12.7 g (86%) 2-amino-4-(methylthio)-6-phenyl-pyrimidine-5-carbonitrile as a sand-coloured solid']"
"['[CH3:1][O:2][C:3]1[CH:4]=[C:5]([CH:11]=[CH:12][CH:13]=1)[C:6]([CH2:8][C:9]#[N:10])=O.[H-].[Na+].CI.[N+]([O-])(O)=O.[NH2:22][C:23]([NH2:25])=[NH:24].[CH3:26][S:27]([CH3:29])=O', 'CN(C=O)C.C(N(CC)CC)C.C(=S)=S', '[NH2:24][C:23]1[N:25]=[C:6]([C:5]2[CH:11]=[CH:12][CH:13]=[C:3]([O:2][CH3:1])[CH:4]=2)[C:8]([C:9]#[N:10])=[C:26]([S:27][CH3:29])[N:22]=1 |f:1.2,4.5|']","['US20010027196A1', '2-Amino-4-(m-methoxyphenyl)-6-(methylthio)-pyrimidine-5-carbonitrile', '0629', 'From 3-methoxybenzoylacetonitrile with sodium hydride, carbon disulphide and methyl iodide in DMSO. Then treatment with guanidine nitrate and triethylamine in DMF. EI-MS m/e (%): 272 (M+, 96), 271 ([M—H]+, 100), 257 ([M—CH3]+, 25).']","[{'chemical_names': ['3-methoxybenzoylacetonitrile'], 'identifiers': ['smiles:COc1cccc(C(=O)CC#N)c1', 'inchi:InChI=1S/C10H9NO2/c1-13-9-4-2-3-8(7-9)10(12)5-6-11/h2-4,7H,5H2,1H3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['sodium hydride'], 'identifiers': ['smiles:[H-].[Na+]', 'inchi:InChI=1S/Na.H/q+1;-1'], 'amounts': [], 'appearances': []}, {'chemical_names': ['methyl iodide'], 'identifiers': ['smiles:CI', 'inchi:InChI=1S/CH3I/c1-2/h1H3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['guanidine nitrate'], 'identifiers': ['smiles:N=C(N)N.O=[N+]([O-])O', 'inchi:InChI=1S/CH5N3.HNO3/c2*2-1(3)4/h(H5,2,3,4);(H,2,3,4)'], 'amounts': [], 'appearances': []}, {'chemical_names': ['DMSO'], 'identifiers': ['smiles:CS(C)=O', 'inchi:InChI=1S/C2H6OS/c1-4(2)3/h1-2H3'], 'amounts': [], 'appearances': []}]","[{'chemical_names': ['2-Amino-4-(m-methoxyphenyl)-6-(methylthio)-pyrimidine-5-carbonitrile'], 'identifiers': ['smiles:COc1cccc(-c2nc(N)nc(SC)c2C#N)c1', 'inchi:InChI=1S/C13H12N4OS/c1-18-9-5-3-4-8(6-9)11-10(7-14)12(19-2)17-13(15)16-11/h3-6H,1-2H3,(H2,15,16,17)'], 'amounts': [], 'appearances': []}]","[{'chemical_names': ['DMF'], 'identifiers': ['smiles:CN(C)C=O', 'inchi:InChI=1S/C3H7NO/c1-4(2)3-5/h3H,1-2H3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['triethylamine'], 'identifiers': ['smiles:CCN(CC)CC', 'inchi:InChI=1S/C6H15N/c1-4-7(5-2)6-3/h4-6H2,1-3H3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['carbon disulphide'], 'identifiers': ['smiles:S=C=S', 'inchi:InChI=1S/CS2/c2-1-3'], 'amounts': [], 'appearances': []}]",[],[]
"['[CH3:1][C:2]1[CH:3]=[C:4]([CH:10]=[CH:11][CH:12]=1)[C:5]([CH2:7][C:8]#[N:9])=O.[H-].[Na+].CI.[N+]([O-])(O)=O.[NH2:21][C:22]([NH2:24])=[NH:23].[CH3:25][S:26]([CH3:28])=O', 'CN(C=O)C.C(N(CC)CC)C.C(=S)=S', '[NH2:23][C:22]1[N:24]=[C:25]([S:26][CH3:28])[C:7]([C:8]#[N:9])=[C:5]([C:4]2[CH:3]=[C:2]([CH3:1])[CH:12]=[CH:11][CH:10]=2)[N:21]=1 |f:1.2,4.5|']","['US20010027196A1', '2-Amino-4-(methylthio)-6-m-tolyl-pyrimidine-5-carbonitrile', '0631', 'From 3-methylbenzoylacetonitrile with sodium hydride, carbon disulphide and methyl iodide in DMSO. Then treatment with guanidine nitrate and triethylamine in DMF. EI-MS m/e (%): 256 (M+, 74), 255 ([M—H]+, 100), 241 ([M—CH3]+, 98).']","[{'chemical_names': ['3-methylbenzoylacetonitrile'], 'identifiers': ['smiles:Cc1cccc(C(=O)CC#N)c1', 'inchi:InChI=1S/C10H9NO/c1-8-3-2-4-9(7-8)10(12)5-6-11/h2-4,7H,5H2,1H3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['sodium hydride'], 'identifiers': ['smiles:[H-].[Na+]', 'inchi:InChI=1S/Na.H/q+1;-1'], 'amounts': [], 'appearances': []}, {'chemical_names': ['methyl iodide'], 'identifiers': ['smiles:CI', 'inchi:InChI=1S/CH3I/c1-2/h1H3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['guanidine nitrate'], 'identifiers': ['smiles:N=C(N)N.O=[N+]([O-])O', 'inchi:InChI=1S/CH5N3.HNO3/c2*2-1(3)4/h(H5,2,3,4);(H,2,3,4)'], 'amounts': [], 'appearances': []}, {'chemical_names': ['DMSO'], 'identifiers': ['smiles:CS(C)=O', 'inchi:InChI=1S/C2H6OS/c1-4(2)3/h1-2H3'], 'amounts': [], 'appearances': []}]","[{'chemical_names': ['2-Amino-4-(methylthio)-6-m-tolyl-pyrimidine-5-carbonitrile'], 'identifiers': ['smiles:CSc1nc(N)nc(-c2cccc(C)c2)c1C#N', 'inchi:InChI=1S/C13H12N4S/c1-8-4-3-5-9(6-8)11-10(7-14)12(18-2)17-13(15)16-11/h3-6H,1-2H3,(H2,15,16,17)'], 'amounts': [], 'appearances': []}]","[{'chemical_names': ['DMF'], 'identifiers': ['smiles:CN(C)C=O', 'inchi:InChI=1S/C3H7NO/c1-4(2)3-5/h3H,1-2H3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['triethylamine'], 'identifiers': ['smiles:CCN(CC)CC', 'inchi:InChI=1S/C6H15N/c1-4-7(5-2)6-3/h4-6H2,1-3H3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['carbon disulphide'], 'identifiers': ['smiles:S=C=S', 'inchi:InChI=1S/CS2/c2-1-3'], 'amounts': [], 'appearances': []}]",[],[]
"['[Cl:1][C:2]1[CH:12]=[CH:11][C:5]([C:6]([CH2:8][C:9]#[N:10])=O)=[CH:4][CH:3]=1.[H-].[Na+].CI.[N+]([O-])(O)=O.[NH2:21][C:22]([NH2:24])=[NH:23].[CH3:25][S:26]([CH3:28])=O', 'CN(C=O)C.C(N(CC)CC)C.C(=S)=S', '[NH2:23][C:22]1[N:24]=[C:6]([C:5]2[CH:11]=[CH:12][C:2]([Cl:1])=[CH:3][CH:4]=2)[C:8]([C:9]#[N:10])=[C:25]([S:26][CH3:28])[N:21]=1 |f:1.2,4.5|']","['US20010027196A1', '2-Amino-4-(p-chlorophenyl)-6-(methylthio)-pyrimidine-5-carbonitrile', '0633', 'From 4-chlorobenzoylacetonitrile with sodium hydride, carbon disulphide and methyl iodide in DMSO. Then treatment with guanidine nitrate and triethylamine in DMF. EI-MS m/e (%): 278 (M{37Cl}+, 14), 277 ([M{37Cl}—H]+, 42), 276 (M{35Cl} +, 46), 275 ([M{35Cl}—H]+, 100), 241 ([M—Cl]+, 30).']","[{'chemical_names': ['4-chlorobenzoylacetonitrile'], 'identifiers': ['smiles:N#CCC(=O)c1ccc(Cl)cc1', 'inchi:InChI=1S/C9H6ClNO/c10-8-3-1-7(2-4-8)9(12)5-6-11/h1-4H,5H2'], 'amounts': [], 'appearances': []}, {'chemical_names': ['sodium hydride'], 'identifiers': ['smiles:[H-].[Na+]', 'inchi:InChI=1S/Na.H/q+1;-1'], 'amounts': [], 'appearances': []}, {'chemical_names': ['methyl iodide'], 'identifiers': ['smiles:CI', 'inchi:InChI=1S/CH3I/c1-2/h1H3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['guanidine nitrate'], 'identifiers': ['smiles:N=C(N)N.O=[N+]([O-])O', 'inchi:InChI=1S/CH5N3.HNO3/c2*2-1(3)4/h(H5,2,3,4);(H,2,3,4)'], 'amounts': [], 'appearances': []}, {'chemical_names': ['M{37Cl}—H'], 'identifiers': [], 'amounts': [], 'appearances': []}, {'chemical_names': ['M{35Cl}—H'], 'identifiers': [], 'amounts': [], 'appearances': []}, {'chemical_names': ['DMSO'], 'identifiers': ['smiles:CS(C)=O', 'inchi:InChI=1S/C2H6OS/c1-4(2)3/h1-2H3'], 'amounts': [], 'appearances': []}]","[{'chemical_names': ['2-Amino-4-(p-chlorophenyl)-6-(methylthio)-pyrimidine-5-carbonitrile'], 'identifiers': ['smiles:CSc1nc(N)nc(-c2ccc(Cl)cc2)c1C#N', 'inchi:InChI=1S/C12H9ClN4S/c1-18-11-9(6-14)10(16-12(15)17-11)7-2-4-8(13)5-3-7/h2-5H,1H3,(H2,15,16,17)'], 'amounts': [], 'appearances': []}]","[{'chemical_names': ['DMF'], 'identifiers': ['smiles:CN(C)C=O', 'inchi:InChI=1S/C3H7NO/c1-4(2)3-5/h3H,1-2H3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['triethylamine'], 'identifiers': ['smiles:CCN(CC)CC', 'inchi:InChI=1S/C6H15N/c1-4-7(5-2)6-3/h4-6H2,1-3H3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['carbon disulphide'], 'identifiers': ['smiles:S=C=S', 'inchi:InChI=1S/CS2/c2-1-3'], 'amounts': [], 'appearances': []}]",[],[]
"['[CH3:1][O:2][C:3]1[CH:13]=[CH:12][C:6]([C:7]([CH2:9][C:10]#[N:11])=O)=[CH:5][CH:4]=1.[H-].[Na+].CI.[N+]([O-])(O)=O.[NH2:22][C:23]([NH2:25])=[NH:24].[CH3:26][S:27]([CH3:29])=O', 'CN(C=O)C.C(N(CC)CC)C.C(=S)=S', '[NH2:24][C:23]1[N:25]=[C:7]([C:6]2[CH:12]=[CH:13][C:3]([O:2][CH3:1])=[CH:4][CH:5]=2)[C:9]([C:10]#[N:11])=[C:26]([S:27][CH3:29])[N:22]=1 |f:1.2,4.5|']","['US20010027196A1', '2-Amino-4-(p-methoxyphenyl)-6-(methylthio)-pyrimidine-5-carbonitrile', '0635', 'From 4-methoxybenzoylacetonitrile with sodium hydride, carbon disulphide and methyl iodide in DMSO. Then treatment with guanidine nitrate and triethylamine in DMF. EI-MS m/e (%): 272 (M+, 96), 271 ([M—H]+, 100), 257 ([M—CH3]+, 25).']","[{'chemical_names': ['4-methoxybenzoylacetonitrile'], 'identifiers': ['smiles:COc1ccc(C(=O)CC#N)cc1', 'inchi:InChI=1S/C10H9NO2/c1-13-9-4-2-8(3-5-9)10(12)6-7-11/h2-5H,6H2,1H3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['sodium hydride'], 'identifiers': ['smiles:[H-].[Na+]', 'inchi:InChI=1S/Na.H/q+1;-1'], 'amounts': [], 'appearances': []}, {'chemical_names': ['methyl iodide'], 'identifiers': ['smiles:CI', 'inchi:InChI=1S/CH3I/c1-2/h1H3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['guanidine nitrate'], 'identifiers': ['smiles:N=C(N)N.O=[N+]([O-])O', 'inchi:InChI=1S/CH5N3.HNO3/c2*2-1(3)4/h(H5,2,3,4);(H,2,3,4)'], 'amounts': [], 'appearances': []}, {'chemical_names': ['DMSO'], 'identifiers': ['smiles:CS(C)=O', 'inchi:InChI=1S/C2H6OS/c1-4(2)3/h1-2H3'], 'amounts': [], 'appearances': []}]","[{'chemical_names': ['2-Amino-4-(p-methoxyphenyl)-6-(methylthio)-pyrimidine-5-carbonitrile'], 'identifiers': ['smiles:COc1ccc(-c2nc(N)nc(SC)c2C#N)cc1', 'inchi:InChI=1S/C13H12N4OS/c1-18-9-5-3-8(4-6-9)11-10(7-14)12(19-2)17-13(15)16-11/h3-6H,1-2H3,(H2,15,16,17)'], 'amounts': [], 'appearances': []}]","[{'chemical_names': ['DMF'], 'identifiers': ['smiles:CN(C)C=O', 'inchi:InChI=1S/C3H7NO/c1-4(2)3-5/h3H,1-2H3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['triethylamine'], 'identifiers': ['smiles:CCN(CC)CC', 'inchi:InChI=1S/C6H15N/c1-4-7(5-2)6-3/h4-6H2,1-3H3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['carbon disulphide'], 'identifiers': ['smiles:S=C=S', 'inchi:InChI=1S/CS2/c2-1-3'], 'amounts': [], 'appearances': []}]",[],[]
"['[C:1]1([C:6]([CH2:8][C:9]#[N:10])=O)[S:5][CH:4]=[CH:3][CH:2]=1.[H-].[Na+].CI.[N+]([O-])(O)=O.[NH2:19][C:20]([NH2:22])=[NH:21].[CH3:23][S:24]([CH3:26])=O', 'CN(C=O)C.C(N(CC)CC)C.C(=S)=S', '[NH2:21][C:20]1[N:22]=[C:23]([S:24][CH3:26])[C:8]([C:9]#[N:10])=[C:6]([C:1]2[S:5][CH:4]=[CH:3][CH:2]=2)[N:19]=1 |f:1.2,4.5|']","['US20010027196A1', '2-Amino-4-(methylthio)-6-(2-thienyl)-pyrimidine-5-carbonitrile', '0639', 'From 2-thenoylacetonitrile with sodium hydride, carbon disulphide and methyl iodide in DMSO. Then treatment with guanidine nitrate and triethylamine in DMF. EI-MS m/e (%): 248 (M+, 42), 247 ([M—H]+, 100).']","[{'chemical_names': ['2-thenoylacetonitrile'], 'identifiers': ['smiles:N#CCC(=O)c1cccs1', 'inchi:InChI=1S/C7H5NOS/c8-4-3-6(9)7-2-1-5-10-7/h1-2,5H,3H2'], 'amounts': [], 'appearances': []}, {'chemical_names': ['sodium hydride'], 'identifiers': ['smiles:[H-].[Na+]', 'inchi:InChI=1S/Na.H/q+1;-1'], 'amounts': [], 'appearances': []}, {'chemical_names': ['methyl iodide'], 'identifiers': ['smiles:CI', 'inchi:InChI=1S/CH3I/c1-2/h1H3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['guanidine nitrate'], 'identifiers': ['smiles:N=C(N)N.O=[N+]([O-])O', 'inchi:InChI=1S/CH5N3.HNO3/c2*2-1(3)4/h(H5,2,3,4);(H,2,3,4)'], 'amounts': [], 'appearances': []}, {'chemical_names': ['DMSO'], 'identifiers': ['smiles:CS(C)=O', 'inchi:InChI=1S/C2H6OS/c1-4(2)3/h1-2H3'], 'amounts': [], 'appearances': []}]","[{'chemical_names': ['2-Amino-4-(methylthio)-6-(2-thienyl)-pyrimidine-5-carbonitrile'], 'identifiers': ['smiles:CSc1nc(N)nc(-c2cccs2)c1C#N', 'inchi:InChI=1S/C10H8N4S2/c1-15-9-6(5-11)8(13-10(12)14-9)7-3-2-4-16-7/h2-4H,1H3,(H2,12,13,14)'], 'amounts': [], 'appearances': []}]","[{'chemical_names': ['DMF'], 'identifiers': ['smiles:CN(C)C=O', 'inchi:InChI=1S/C3H7NO/c1-4(2)3-5/h3H,1-2H3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['triethylamine'], 'identifiers': ['smiles:CCN(CC)CC', 'inchi:InChI=1S/C6H15N/c1-4-7(5-2)6-3/h4-6H2,1-3H3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['carbon disulphide'], 'identifiers': ['smiles:S=C=S', 'inchi:InChI=1S/CS2/c2-1-3'], 'amounts': [], 'appearances': []}]",[],[]
"['[O:1]1[CH:5]=[CH:4][CH:3]=[C:2]1[C:6]([CH2:8][C:9]#[N:10])=O.[H-].[Na+].CI.[N+]([O-])(O)=O.[NH2:19][C:20]([NH2:22])=[NH:21].[CH3:23][S:24]([CH3:26])=O', 'CN(C=O)C.C(N(CC)CC)C.C(=S)=S', '[NH2:21][C:20]1[N:22]=[C:6]([C:2]2[O:1][CH:5]=[CH:4][CH:3]=2)[C:8]([C:9]#[N:10])=[C:23]([S:24][CH3:26])[N:19]=1 |f:1.2,4.5|']","['US20010027196A1', '2-Amino-4-(2-furyl)-6-(methylthio)-pyrimidine-5-carbonitrile', '0641', 'From 2-furoylacetonitrile with sodium hydride, carbon disulphide and methyl iodide in DMSO. Then treatment with guanidine nitrate and triethylamine in DMF. EI-MS m/e (%):232 (M+, 40), 231 ([M—H]+, 100).']","[{'chemical_names': ['2-furoylacetonitrile'], 'identifiers': ['smiles:N#CCC(=O)c1ccco1', 'inchi:InChI=1S/C7H5NO2/c8-4-3-6(9)7-2-1-5-10-7/h1-2,5H,3H2'], 'amounts': [], 'appearances': []}, {'chemical_names': ['sodium hydride'], 'identifiers': ['smiles:[H-].[Na+]', 'inchi:InChI=1S/Na.H/q+1;-1'], 'amounts': [], 'appearances': []}, {'chemical_names': ['methyl iodide'], 'identifiers': ['smiles:CI', 'inchi:InChI=1S/CH3I/c1-2/h1H3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['guanidine nitrate'], 'identifiers': ['smiles:N=C(N)N.O=[N+]([O-])O', 'inchi:InChI=1S/CH5N3.HNO3/c2*2-1(3)4/h(H5,2,3,4);(H,2,3,4)'], 'amounts': [], 'appearances': []}, {'chemical_names': ['DMSO'], 'identifiers': ['smiles:CS(C)=O', 'inchi:InChI=1S/C2H6OS/c1-4(2)3/h1-2H3'], 'amounts': [], 'appearances': []}]","[{'chemical_names': ['2-Amino-4-(2-furyl)-6-(methylthio)-pyrimidine-5-carbonitrile'], 'identifiers': ['smiles:CSc1nc(N)nc(-c2ccco2)c1C#N', 'inchi:InChI=1S/C10H8N4OS/c1-16-9-6(5-11)8(13-10(12)14-9)7-3-2-4-15-7/h2-4H,1H3,(H2,12,13,14)'], 'amounts': [], 'appearances': []}]","[{'chemical_names': ['DMF'], 'identifiers': ['smiles:CN(C)C=O', 'inchi:InChI=1S/C3H7NO/c1-4(2)3-5/h3H,1-2H3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['triethylamine'], 'identifiers': ['smiles:CCN(CC)CC', 'inchi:InChI=1S/C6H15N/c1-4-7(5-2)6-3/h4-6H2,1-3H3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['carbon disulphide'], 'identifiers': ['smiles:S=C=S', 'inchi:InChI=1S/CS2/c2-1-3'], 'amounts': [], 'appearances': []}]",[],[]
"['[CH3:1][O:2][C:3]1[CH:4]=[C:5]([CH:11]=[C:12]([O:16][CH3:17])[C:13]=1[O:14][CH3:15])[C:6]([CH2:8][C:9]#[N:10])=O.[H-].[Na+].CI.[N+]([O-])(O)=O.[NH2:26][C:27]([NH2:29])=[NH:28].[CH3:30][S:31]([CH3:33])=O', 'CN(C=O)C.C(N(CC)CC)C.C(=S)=S', '[NH2:28][C:27]1[N:29]=[C:30]([S:31][CH3:33])[C:8]([C:9]#[N:10])=[C:6]([C:5]2[CH:4]=[C:3]([O:2][CH3:1])[C:13]([O:14][CH3:15])=[C:12]([O:16][CH3:17])[CH:11]=2)[N:26]=1 |f:1.2,4.5|']","['US20010027196A1', '2-Amino-4-methylsulfanyl-6-(3,4,5-trimethoxy-phenyl)-pyrimidine-5-carbonitrile', '0662', 'From 3,4,5-trimethoxybenzoylacetonitrile with sodium hydride, carbon disulphide and methyl iodide in DMSO. Then treatment with guanidine nitrate and triethylamine in DMF. EI-MS m/e (%): 332 (M+, 100), 317 ([M—CH3]+, 36).']","[{'chemical_names': ['3,4,5-trimethoxybenzoylacetonitrile'], 'identifiers': ['smiles:COc1cc(C(=O)CC#N)cc(OC)c1OC', 'inchi:InChI=1S/C12H13NO4/c1-15-10-6-8(9(14)4-5-13)7-11(16-2)12(10)17-3/h6-7H,4H2,1-3H3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['sodium hydride'], 'identifiers': ['smiles:[H-].[Na+]', 'inchi:InChI=1S/Na.H/q+1;-1'], 'amounts': [], 'appearances': []}, {'chemical_names': ['methyl iodide'], 'identifiers': ['smiles:CI', 'inchi:InChI=1S/CH3I/c1-2/h1H3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['guanidine nitrate'], 'identifiers': ['smiles:N=C(N)N.O=[N+]([O-])O', 'inchi:InChI=1S/CH5N3.HNO3/c2*2-1(3)4/h(H5,2,3,4);(H,2,3,4)'], 'amounts': [], 'appearances': []}, {'chemical_names': ['DMSO'], 'identifiers': ['smiles:CS(C)=O', 'inchi:InChI=1S/C2H6OS/c1-4(2)3/h1-2H3'], 'amounts': [], 'appearances': []}]","[{'chemical_names': ['2-Amino-4-methylsulfanyl-6-(3,4,5-trimethoxy-phenyl)-pyrimidine-5-carbonitrile'], 'identifiers': ['smiles:COc1cc(-c2nc(N)nc(SC)c2C#N)cc(OC)c1OC', 'inchi:InChI=1S/C15H16N4O3S/c1-20-10-5-8(6-11(21-2)13(10)22-3)12-9(7-16)14(23-4)19-15(17)18-12/h5-6H,1-4H3,(H2,17,18,19)'], 'amounts': [], 'appearances': []}]","[{'chemical_names': ['DMF'], 'identifiers': ['smiles:CN(C)C=O', 'inchi:InChI=1S/C3H7NO/c1-4(2)3-5/h3H,1-2H3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['triethylamine'], 'identifiers': ['smiles:CCN(CC)CC', 'inchi:InChI=1S/C6H15N/c1-4-7(5-2)6-3/h4-6H2,1-3H3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['carbon disulphide'], 'identifiers': ['smiles:S=C=S', 'inchi:InChI=1S/CS2/c2-1-3'], 'amounts': [], 'appearances': []}]",[],[]
"['[O:1]1[C:6]2[CH:7]=[CH:8][C:9]([C:11](=O)[CH2:12][C:13]#[N:14])=[CH:10][C:5]=2[O:4][CH2:3][CH2:2]1.[H-].[Na+].CI.[N+]([O-])(O)=O.[NH2:24][C:25]([NH2:27])=[NH:26].[CH3:28][S:29]([CH3:31])=O', 'CN(C=O)C.C(N(CC)CC)C.C(=S)=S', '[NH2:26][C:25]1[N:27]=[C:11]([C:9]2[CH:8]=[CH:7][C:6]3[O:1][CH2:2][CH2:3][O:4][C:5]=3[CH:10]=2)[C:12]([C:13]#[N:14])=[C:28]([S:29][CH3:31])[N:24]=1 |f:1.2,4.5|']","['US20010027196A1', '2-Amino-4-(2,3-dihydro-benzo[1,4]dioxin-6-yl)-6-methylsulfanyl-pyrimidine-5-carbonitrile', '0692', 'From 3-(2,3-dihydro-benzo[1,4]dioxin-6-yl)-3-oxo-propionitrile with sodium hydride, carbon disulphide and methyl iodide in DMSO. Then treatment with guanidine nitrate and triethylamine in DMF. EI-MS m/e (%):300 (M+, 100), 299 ([M—H]+, 92).']","[{'chemical_names': ['3-(2,3-dihydro-benzo[1,4]dioxin-6-yl)-3-oxo-propionitrile'], 'identifiers': ['smiles:N#CCC(=O)c1ccc2c(c1)OCCO2', 'inchi:InChI=1S/C11H9NO3/c12-4-3-9(13)8-1-2-10-11(7-8)15-6-5-14-10/h1-2,7H,3,5-6H2'], 'amounts': [], 'appearances': []}, {'chemical_names': ['sodium hydride'], 'identifiers': ['smiles:[H-].[Na+]', 'inchi:InChI=1S/Na.H/q+1;-1'], 'amounts': [], 'appearances': []}, {'chemical_names': ['methyl iodide'], 'identifiers': ['smiles:CI', 'inchi:InChI=1S/CH3I/c1-2/h1H3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['guanidine nitrate'], 'identifiers': ['smiles:N=C(N)N.O=[N+]([O-])O', 'inchi:InChI=1S/CH5N3.HNO3/c2*2-1(3)4/h(H5,2,3,4);(H,2,3,4)'], 'amounts': [], 'appearances': []}, {'chemical_names': ['DMSO'], 'identifiers': ['smiles:CS(C)=O', 'inchi:InChI=1S/C2H6OS/c1-4(2)3/h1-2H3'], 'amounts': [], 'appearances': []}]","[{'chemical_names': ['2-Amino-4-(2,3-dihydro-benzo[1,4]dioxin-6-yl)-6-methylsulfanyl-pyrimidine-5-carbonitrile'], 'identifiers': ['smiles:CSc1nc(N)nc(-c2ccc3c(c2)OCCO3)c1C#N', 'inchi:InChI=1S/C14H12N4O2S/c1-21-13-9(7-15)12(17-14(16)18-13)8-2-3-10-11(6-8)20-5-4-19-10/h2-3,6H,4-5H2,1H3,(H2,16,17,18)'], 'amounts': [], 'appearances': []}]","[{'chemical_names': ['DMF'], 'identifiers': ['smiles:CN(C)C=O', 'inchi:InChI=1S/C3H7NO/c1-4(2)3-5/h3H,1-2H3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['triethylamine'], 'identifiers': ['smiles:CCN(CC)CC', 'inchi:InChI=1S/C6H15N/c1-4-7(5-2)6-3/h4-6H2,1-3H3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['carbon disulphide'], 'identifiers': ['smiles:S=C=S', 'inchi:InChI=1S/CS2/c2-1-3'], 'amounts': [], 'appearances': []}]",[],[]
"['[O:1]1[C:5]2[CH:6]=[CH:7][C:8]([C:10](=O)[CH2:11][C:12]#[N:13])=[CH:9][C:4]=2[O:3][CH2:2]1.[H-].[Na+].CI.[N+]([O-])(O)=O.[NH2:23][C:24]([NH2:26])=[NH:25].[CH3:27][S:28]([CH3:30])=O', 'CN(C=O)C.C(N(CC)CC)C.C(=S)=S', '[NH2:25][C:24]1[N:26]=[C:10]([C:8]2[CH:7]=[CH:6][C:5]3[O:1][CH2:2][O:3][C:4]=3[CH:9]=2)[C:11]([C:12]#[N:13])=[C:27]([S:28][CH3:30])[N:23]=1 |f:1.2,4.5|']","['US20010027196A1', '2-Amino-4-benzo[1,3]dioxol-5-yl-6-methylsulfanyl-pyrimidine-5-carbonitrile', '0694', 'From 3-benzo[1,3]dioxol-5-yl-3-oxo-propionitrile with sodium hydride, carbon disulphide and methyl iodide in DMSO. Then treatment with guanidine nitrate and triethylamine in DMF. EI-MS m/e (%):286 (M+, 96), 285 ([M—H]+, 100).']","[{'chemical_names': ['3-benzo[1,3]dioxol-5-yl-3-oxo-propionitrile'], 'identifiers': ['smiles:N#CCC(=O)c1ccc2c(c1)OCO2', 'inchi:InChI=1S/C10H7NO3/c11-4-3-8(12)7-1-2-9-10(5-7)14-6-13-9/h1-2,5H,3,6H2'], 'amounts': [], 'appearances': []}, {'chemical_names': ['sodium hydride'], 'identifiers': ['smiles:[H-].[Na+]', 'inchi:InChI=1S/Na.H/q+1;-1'], 'amounts': [], 'appearances': []}, {'chemical_names': ['methyl iodide'], 'identifiers': ['smiles:CI', 'inchi:InChI=1S/CH3I/c1-2/h1H3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['guanidine nitrate'], 'identifiers': ['smiles:N=C(N)N.O=[N+]([O-])O', 'inchi:InChI=1S/CH5N3.HNO3/c2*2-1(3)4/h(H5,2,3,4);(H,2,3,4)'], 'amounts': [], 'appearances': []}, {'chemical_names': ['DMSO'], 'identifiers': ['smiles:CS(C)=O', 'inchi:InChI=1S/C2H6OS/c1-4(2)3/h1-2H3'], 'amounts': [], 'appearances': []}]","[{'chemical_names': ['2-Amino-4-benzo[1,3]dioxol-5-yl-6-methylsulfanyl-pyrimidine-5-carbonitrile'], 'identifiers': ['smiles:CSc1nc(N)nc(-c2ccc3c(c2)OCO3)c1C#N', 'inchi:InChI=1S/C13H10N4O2S/c1-20-12-8(5-14)11(16-13(15)17-12)7-2-3-9-10(4-7)19-6-18-9/h2-4H,6H2,1H3,(H2,15,16,17)'], 'amounts': [], 'appearances': []}]","[{'chemical_names': ['DMF'], 'identifiers': ['smiles:CN(C)C=O', 'inchi:InChI=1S/C3H7NO/c1-4(2)3-5/h3H,1-2H3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['triethylamine'], 'identifiers': ['smiles:CCN(CC)CC', 'inchi:InChI=1S/C6H15N/c1-4-7(5-2)6-3/h4-6H2,1-3H3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['carbon disulphide'], 'identifiers': ['smiles:S=C=S', 'inchi:InChI=1S/CS2/c2-1-3'], 'amounts': [], 'appearances': []}]",[],[]
"['[NH2:1][C:2]1[N:7]=[C:6](Cl)[C:5]([C:9]#[N:10])=[C:4]([C:11]2[CH:16]=[CH:15][CH:14]=[CH:13][CH:12]=2)[N:3]=1.[C:17]1([C:23]#[CH:24])[CH:22]=[CH:21][CH:20]=[CH:19][CH:18]=1.C(N(CC)CC)C', 'Cl[Pd](Cl)([P](C1C=CC=CC=1)(C1C=CC=CC=1)C1C=CC=CC=1)[P](C1C=CC=CC=1)(C1C=CC=CC=1)C1C=CC=CC=1.[Cu]I.C1(P(C2C=CC=CC=2)C2C=CC=CC=2)C=CC=CC=1', '[NH2:1][C:2]1[N:3]=[C:4]([C:11]2[CH:16]=[CH:15][CH:14]=[CH:13][CH:12]=2)[C:5]([C:9]#[N:10])=[C:6]([C:24]#[C:23][C:17]2[CH:22]=[CH:21][CH:20]=[CH:19][CH:18]=2)[N:7]=1 |^1:34,53|']","['US20010027196A1', '0940', 'Following the method of Thorand and Krause (J. Org Chem. 1998, 63, 8551), to a stirred solution of 500 mg (2.17 mmol) 2-amino-4-chloro-6-phenyl-pyrimidine-5-carbonitrile in 8.5 ml dry degassed THF under argon at room temperature were added 300 mg (0.43 mmol) bis(triphenylphosphine)palladium(II) chloride, 14 mg (0.05 mmol) triphenylphosphine, 0.36 ml (3.28 mmol) phenylacetylene and 0.45 ml (3.23 mmol) triethylamine. Stirring was continued for 30 minutes then 4.0 mg (0.02 mmol) copper(I) iodide was added and the reaction mixture stirred for an additional 16 hours at room temperature. The reaction mixture was then concentrated in vacuo. Chromatography (1/2 ethyl acetate/hexane) afforded 350 mg (55%) 2-amino-4-phenyl-6-phenylethynyl-pyrimidine-5-carbonitrile as a light yellow crystalline solid. EI-MS m/e (%): 296 (M+, 100), 270 (80).']","[{'chemical_names': ['2-amino-4-chloro-6-phenyl-pyrimidine-5-carbonitrile'], 'identifiers': ['smiles:N#Cc1c(Cl)nc(N)nc1-c1ccccc1', 'inchi:InChI=1S/C11H7ClN4/c12-10-8(6-13)9(15-11(14)16-10)7-4-2-1-3-5-7/h1-5H,(H2,14,15,16)'], 'amounts': ['2.17 mmol', '500 mg'], 'appearances': []}, {'chemical_names': ['phenylacetylene'], 'identifiers': ['smiles:C#Cc1ccccc1', 'inchi:InChI=1S/C8H6/c1-2-8-6-4-3-5-7-8/h1,3-7H'], 'amounts': ['3.28 mmol', '0.36 ml'], 'appearances': []}, {'chemical_names': ['triethylamine'], 'identifiers': ['smiles:CCN(CC)CC', 'inchi:InChI=1S/C6H15N/c1-4-7(5-2)6-3/h4-6H2,1-3H3'], 'amounts': ['3.23 mmol', '0.45 ml'], 'appearances': []}]","[{'chemical_names': ['2-amino-4-phenyl-6-phenylethynyl-pyrimidine-5-carbonitrile'], 'identifiers': ['smiles:N#Cc1c(C#Cc2ccccc2)nc(N)nc1-c1ccccc1', 'inchi:InChI=1S/C19H12N4/c20-13-16-17(12-11-14-7-3-1-4-8-14)22-19(21)23-18(16)15-9-5-2-6-10-15/h1-10H,(H2,21,22,23)'], 'amounts': ['350 mg', '55%', '54.4'], 'appearances': ['light yellow crystalline']}]",[],"[{'chemical_names': ['bis(triphenylphosphine)palladium(II) chloride'], 'identifiers': ['smiles:Cl[Pd](Cl)([P](c1ccccc1)(c1ccccc1)c1ccccc1)[P](c1ccccc1)(c1ccccc1)c1ccccc1', 'inchi:InChI=1S/2C18H15P.2ClH.Pd/c2*1-4-10-16(11-5-1)19(17-12-6-2-7-13-17)18-14-8-3-9-15-18;;;/h2*1-15H;2*1H;/q;;;;+2/p-2'], 'amounts': ['0.43 mmol', '300 mg'], 'appearances': []}, {'chemical_names': ['copper(I) iodide'], 'identifiers': ['smiles:[Cu]I', 'inchi:InChI=1S/Cu.HI/h;1H/q+1;/p-1'], 'amounts': ['0.02 mmol', '4.0 mg'], 'appearances': []}, {'chemical_names': ['triphenylphosphine'], 'identifiers': ['smiles:c1ccc(P(c2ccccc2)c2ccccc2)cc1', 'inchi:InChI=1S/C18H15P/c1-4-10-16(11-5-1)19(17-12-6-2-7-13-17)18-14-8-3-9-15-18/h1-15H'], 'amounts': ['0.05 mmol', '14 mg'], 'appearances': []}]","['step 1:to a stirred solution of 500 mg (2.17 mmol) 2-amino-4-chloro-6-phenyl-pyrimidine-5-carbonitrile in 8.5 ml dry', 'step 2:degassed THF under argon at room temperature', 'step 2 properties:Temperature:room temperature', 'step 3:were added 300 mg (0.43 mmol) bis(triphenylphosphine)palladium(II) chloride, 14 mg (0.05 mmol) triphenylphosphine, 0.36 ml (3.28 mmol) phenylacetylene and 0.45 ml (3.23 mmol) triethylamine', 'step 4:Stirring', 'step 5:was continued for 30 minutes', 'step 5 properties:Time:1800', 'step 6:4.0 mg (0.02 mmol) copper(I) iodide was added', 'step 7:the reaction mixture stirred for an additional 16 hours at room temperature', 'step 7 properties:Time:57600', 'step 7 properties:Temperature:room temperature', 'step 8:The reaction mixture was then concentrated in vacuo', 'step 9:Chromatography (1/2 ethyl acetate/hexane) afforded 350 mg (55%) 2-amino-4-phenyl-6-phenylethynyl-pyrimidine-5-carbonitrile as a light yellow crystalline solid']"
"['[C:1](#[N:7])[CH:2]([CH2:4][C:5]#N)O.[C:8]([CH2:10][C:11]([NH2:13])=[S:12])#[N:9].[CH:14](=[O:20])[C:15]1OC=C[CH:16]=1.[CH3:21][N:22](C=O)C', 'C(O)C.C(N(CC)CC)C', '[NH2:13][C:11]1[S:12][C:21]([NH2:22])=[C:2]([C:1]#[N:7])[CH:4]([C:5]2[O:20][CH:14]=[CH:15][CH:16]=2)[C:10]=1[C:8]#[N:9]']","['US20010027196A1', '0973', 'Following an adaptation of the method of Elghandour et al. (Ind. J. Chem. 1997, B36, 79), to a stirred solution of 3.98 g (60.3 mmol) malonitrile, 6.04 g (60.3 mmol) cyanothioacetamide and 5.0 ml (60.3 mmol) furfural in 100 ml ethanol and 5 ml DMF at 0° C. was added dropwise 0.4 ml (3.0 mmol) triethylamine and stirring was continued at 0° C. for 2 hours. The resulting crystals were collected by filtration and washed with ice-cold ether to afford 10.4 g (71%) 2,6-diamino-4-furan-2-yl-4H-thiopyran-3,5-dicarbonitrile as a white crystalline solid. EI-MS m/e (%): 244 (M+, 100), 211 ([M—SH]+, 64), 60 (50).']","[{'chemical_names': ['malonitrile'], 'identifiers': ['smiles:N#CCC(O)C#N', 'inchi:InChI=1S/C4H4N2O/c5-2-1-4(7)3-6/h4,7H,1H2'], 'amounts': ['60.3 mmol', '3.98 g'], 'appearances': []}, {'chemical_names': ['cyanothioacetamide'], 'identifiers': ['smiles:N#CCC(N)=S', 'inchi:InChI=1S/C3H4N2S/c4-2-1-3(5)6/h1H2,(H2,5,6)'], 'amounts': ['60.3 mmol', '6.04 g'], 'appearances': []}, {'chemical_names': ['furfural'], 'identifiers': ['smiles:O=Cc1ccco1', 'inchi:InChI=1S/C5H4O2/c6-4-5-2-1-3-7-5/h1-4H'], 'amounts': ['60.3 mmol', '5.0 ml'], 'appearances': []}, {'chemical_names': ['DMF'], 'identifiers': ['smiles:CN(C)C=O', 'inchi:InChI=1S/C3H7NO/c1-4(2)3-5/h3H,1-2H3'], 'amounts': ['5 ml'], 'appearances': []}]","[{'chemical_names': ['2,6-diamino-4-furan-2-yl-4H-thiopyran-3,5-dicarbonitrile'], 'identifiers': ['smiles:N#CC1=C(N)SC(N)=C(C#N)C1c1ccco1', 'inchi:InChI=1S/C11H8N4OS/c12-4-6-9(8-2-1-3-16-8)7(5-13)11(15)17-10(6)14/h1-3,9H,14-15H2'], 'amounts': ['10.4 g', '71%'], 'appearances': ['white crystalline']}]","[{'chemical_names': ['ethanol'], 'identifiers': ['smiles:CCO', 'inchi:InChI=1S/C2H6O/c1-2-3/h3H,2H2,1H3'], 'amounts': ['100 ml'], 'appearances': []}]","[{'chemical_names': ['triethylamine'], 'identifiers': ['smiles:CCN(CC)CC', 'inchi:InChI=1S/C6H15N/c1-4-7(5-2)6-3/h4-6H2,1-3H3'], 'amounts': ['3.0 mmol', '0.4 ml'], 'appearances': []}]","['step 1:to a stirred solution of 3.98 g (60.3 mmol) malonitrile, 6.04 g (60.3 mmol) cyanothioacetamide and 5.0 ml (60.3 mmol) furfural in 100 ml ethanol and 5 ml DMF at 0° C. was added dropwise 0.4 ml (3.0 mmol) triethylamine', 'step 1 properties:Temperature:0', 'step 2:stirring', 'step 3:was continued at 0° C. for 2 hours', 'step 3 properties:Time:7200', 'step 3 properties:Temperature:0', 'step 4:The resulting crystals were collected by filtration', 'step 5:washed with ice-cold ether', 'step 6:to afford 10.4 g (71%) 2,6-diamino-4-furan-2-yl-4H-thiopyran-3,5-dicarbonitrile as a white crystalline solid']"
"['[O:1]1[CH:5]=[CH:4][CH:3]=[C:2]1[C:6]1[C:11](I)=[C:10]([S:13][CH3:14])[N:9]=[C:8]([NH2:15])[N:7]=1.[C:16]1([C:22]#[CH:23])[CH:21]=[CH:20][CH:19]=[CH:18][CH:17]=1.C(N(CC)CC)C', 'Cl[Pd](Cl)([P](C1C=CC=CC=1)(C1C=CC=CC=1)C1C=CC=CC=1)[P](C1C=CC=CC=1)(C1C=CC=CC=1)C1C=CC=CC=1.[Cu]I.C1(P(C2C=CC=CC=2)C2C=CC=CC=2)C=CC=CC=1', '[O:1]1[CH:5]=[CH:4][CH:3]=[C:2]1[C:6]1[C:11]([C:23]#[C:22][C:16]2[CH:21]=[CH:20][CH:19]=[CH:18][CH:17]=2)=[C:10]([S:13][CH3:14])[N:9]=[C:8]([NH2:15])[N:7]=1 |^1:33,52|']","['US20010027196A1', '0984', 'Following the method of Thorand and Krause (J. Org. Chem. 1998, 63, 8551), to a stirred solution of 500 mg (1.50 mmol) 4-furan-2-yl-5-iodo-6-methylsulfanyl-pyrimidin-2-ylamine in 10 ml dry degassed THF under argon at room temperature were added 211 mg (0.30 mmol) bis(triphenylphosphine)palladium(II) chloride, 10 mg (0.04 mmol) triphenylphosphine, 0.25 ml (2.28 mmol) phenylacetylene and 0.31 ml (2.22 mmol) triethylamine. Stirring was continued for 30 minutes then 3.0 mg (0.02 mmol) copper(I) iodide was added and the reaction mixture stirred for an additional 72 hours at room temperature. The reaction mixture was then concentrated in vacuo. Chromatography (1/4-1/1 ethyl acetate/hexane) afforded 161 mg (35%) 4-furan-2-yl-6-methylsulfanyl-5-phenylethynyl-pyrimidin-2-ylamine as a yellow crystalline solid. EI-MS m/e (%): 307 (M+, 100), 306 ([M—H]+, 52), 230 (38).']","[{'chemical_names': ['4-furan-2-yl-5-iodo-6-methylsulfanyl-pyrimidin-2-ylamine'], 'identifiers': ['smiles:CSc1nc(N)nc(-c2ccco2)c1I', 'inchi:InChI=1S/C9H8IN3OS/c1-15-8-6(10)7(12-9(11)13-8)5-3-2-4-14-5/h2-4H,1H3,(H2,11,12,13)'], 'amounts': ['1.50 mmol', '500 mg'], 'appearances': []}, {'chemical_names': ['phenylacetylene'], 'identifiers': ['smiles:C#Cc1ccccc1', 'inchi:InChI=1S/C8H6/c1-2-8-6-4-3-5-7-8/h1,3-7H'], 'amounts': ['2.28 mmol', '0.25 ml'], 'appearances': []}, {'chemical_names': ['triethylamine'], 'identifiers': ['smiles:CCN(CC)CC', 'inchi:InChI=1S/C6H15N/c1-4-7(5-2)6-3/h4-6H2,1-3H3'], 'amounts': ['2.22 mmol', '0.31 ml'], 'appearances': []}]","[{'chemical_names': ['1/4-1/1 ethyl acetate hexane'], 'identifiers': [], 'amounts': [], 'appearances': []}, {'chemical_names': ['4-furan-2-yl-6-methylsulfanyl-5-phenylethynyl-pyrimidin-2-ylamine'], 'identifiers': ['smiles:CSc1nc(N)nc(-c2ccco2)c1C#Cc1ccccc1', 'inchi:InChI=1S/C17H13N3OS/c1-22-16-13(10-9-12-6-3-2-4-7-12)15(19-17(18)20-16)14-8-5-11-21-14/h2-8,11H,1H3,(H2,18,19,20)'], 'amounts': ['161 mg', '35%', '34.9'], 'appearances': ['yellow crystalline']}]",[],"[{'chemical_names': ['bis(triphenylphosphine)palladium(II) chloride'], 'identifiers': ['smiles:Cl[Pd](Cl)([P](c1ccccc1)(c1ccccc1)c1ccccc1)[P](c1ccccc1)(c1ccccc1)c1ccccc1', 'inchi:InChI=1S/2C18H15P.2ClH.Pd/c2*1-4-10-16(11-5-1)19(17-12-6-2-7-13-17)18-14-8-3-9-15-18;;;/h2*1-15H;2*1H;/q;;;;+2/p-2'], 'amounts': ['0.30 mmol', '211 mg'], 'appearances': []}, {'chemical_names': ['copper(I) iodide'], 'identifiers': ['smiles:[Cu]I', 'inchi:InChI=1S/Cu.HI/h;1H/q+1;/p-1'], 'amounts': ['0.02 mmol', '3.0 mg'], 'appearances': []}, {'chemical_names': ['triphenylphosphine'], 'identifiers': ['smiles:c1ccc(P(c2ccccc2)c2ccccc2)cc1', 'inchi:InChI=1S/C18H15P/c1-4-10-16(11-5-1)19(17-12-6-2-7-13-17)18-14-8-3-9-15-18/h1-15H'], 'amounts': ['0.04 mmol', '10 mg'], 'appearances': []}]","['step 1:to a stirred solution of 500 mg (1.50 mmol) 4-furan-2-yl-5-iodo-6-methylsulfanyl-pyrimidin-2-ylamine in 10 ml dry', 'step 2:degassed THF under argon at room temperature', 'step 2 properties:Temperature:room temperature', 'step 3:were added 211 mg (0.30 mmol) bis(triphenylphosphine)palladium(II) chloride, 10 mg (0.04 mmol) triphenylphosphine, 0.25 ml (2.28 mmol) phenylacetylene and 0.31 ml (2.22 mmol) triethylamine', 'step 4:Stirring', 'step 5:was continued for 30 minutes', 'step 5 properties:Time:1800', 'step 6:3.0 mg (0.02 mmol) copper(I) iodide was added', 'step 7:the reaction mixture stirred for an additional 72 hours at room temperature', 'step 7 properties:Time:259200', 'step 7 properties:Temperature:room temperature', 'step 8:The reaction mixture was then concentrated in vacuo', 'step 9:Chromatography (1/4-1/1 ethyl acetate/hexane) afforded 161 mg (35%) 4-furan-2-yl-6-methylsulfanyl-5-phenylethynyl-pyrimidin-2-ylamine as a yellow crystalline solid']"
"['[NH2:1][C:2]1[N:7]=[C:6](OS(C(F)(F)F)(=O)=O)[C:5]([C:16]#[N:17])=[C:4]([C:18]2[O:19][CH:20]=[CH:21][CH:22]=2)[N:3]=1.[C:23]1([C:29]#[CH:30])[CH:28]=[CH:27][CH:26]=[CH:25][CH:24]=1.C1(P(C2C=CC=CC=2)C2C=CC=CC=2)C=CC=CC=1.C(N(CC)CC)C', 'C1COCC1.Cl[Pd](Cl)([P](C1C=CC=CC=1)(C1C=CC=CC=1)C1C=CC=CC=1)[P](C1C=CC=CC=1)(C1C=CC=CC=1)C1C=CC=CC=1.[Cu]I', '[NH2:1][C:2]1[N:3]=[C:4]([C:18]2[O:19][CH:20]=[CH:21][CH:22]=2)[C:5]([C:16]#[N:17])=[C:6]([C:30]#[C:29][C:23]2[CH:28]=[CH:27][CH:26]=[CH:25][CH:24]=2)[N:7]=1 |^1:64,83|']","['US20010027196A1', '2-Amino-4-furan-2-yl-6-phenylethynyl-pyrimidine-5-carbonitrile', '1007', 'From trifluoromethanesulfonic acid 2-amino-5-cyano-6-furan-2-yl-pyrimidin-4-yl ester, phenylacetylene, bis(triphenylphosphine)palladium(II) chloride, triphenylphosphine, triethylamine and copper (I) iodide in THF. EI-MS m/e (%): 286 (M+, 100).']","[{'chemical_names': ['trifluoromethanesulfonic acid 2-amino-5-cyano-6-furan-2-yl-pyrimidin-4-yl ester'], 'identifiers': ['smiles:N#Cc1c(OS(=O)(=O)C(F)(F)F)nc(N)nc1-c1ccco1', 'inchi:InChI=1S/C10H5F3N4O4S/c11-10(12,13)22(18,19)21-8-5(4-14)7(16-9(15)17-8)6-2-1-3-20-6/h1-3H,(H2,15,16,17)'], 'amounts': [], 'appearances': []}, {'chemical_names': ['phenylacetylene'], 'identifiers': ['smiles:C#Cc1ccccc1', 'inchi:InChI=1S/C8H6/c1-2-8-6-4-3-5-7-8/h1,3-7H'], 'amounts': [], 'appearances': []}, {'chemical_names': ['triphenylphosphine'], 'identifiers': ['smiles:c1ccc(P(c2ccccc2)c2ccccc2)cc1', 'inchi:InChI=1S/C18H15P/c1-4-10-16(11-5-1)19(17-12-6-2-7-13-17)18-14-8-3-9-15-18/h1-15H'], 'amounts': [], 'appearances': []}, {'chemical_names': ['triethylamine'], 'identifiers': ['smiles:CCN(CC)CC', 'inchi:InChI=1S/C6H15N/c1-4-7(5-2)6-3/h4-6H2,1-3H3'], 'amounts': [], 'appearances': []}]","[{'chemical_names': ['2-Amino-4-furan-2-yl-6-phenylethynyl-pyrimidine-5-carbonitrile'], 'identifiers': ['smiles:N#Cc1c(C#Cc2ccccc2)nc(N)nc1-c1ccco1', 'inchi:InChI=1S/C17H10N4O/c18-11-13-14(9-8-12-5-2-1-3-6-12)20-17(19)21-16(13)15-7-4-10-22-15/h1-7,10H,(H2,19,20,21)'], 'amounts': [], 'appearances': []}]","[{'chemical_names': ['THF'], 'identifiers': ['smiles:C1CCOC1', 'inchi:InChI=1S/C4H8O/c1-2-4-5-3-1/h1-4H2'], 'amounts': [], 'appearances': []}]","[{'chemical_names': ['bis(triphenylphosphine)palladium(II) chloride'], 'identifiers': ['smiles:Cl[Pd](Cl)([P](c1ccccc1)(c1ccccc1)c1ccccc1)[P](c1ccccc1)(c1ccccc1)c1ccccc1', 'inchi:InChI=1S/2C18H15P.2ClH.Pd/c2*1-4-10-16(11-5-1)19(17-12-6-2-7-13-17)18-14-8-3-9-15-18;;;/h2*1-15H;2*1H;/q;;;;+2/p-2'], 'amounts': [], 'appearances': []}, {'chemical_names': ['copper (I) iodide'], 'identifiers': ['smiles:[Cu]I', 'inchi:InChI=1S/Cu.HI/h;1H/q+1;/p-1'], 'amounts': [], 'appearances': []}]",[]
"['O=[C:2]([C:9]1[O:10][CH:11]=[CH:12][CH:13]=1)[CH2:3][C:4]([O:6][CH2:7][CH3:8])=[O:5].[H-].[Na+].CI.[N+]([O-])(O)=O.[NH2:22][C:23]([NH2:25])=[NH:24].[CH3:26][S:27]([CH3:29])=O', 'CN(C=O)C.C(N(CC)CC)C.C(=S)=S', '[CH2:7]([O:6][C:4]([C:3]1[C:2]([C:9]2[O:10][CH:11]=[CH:12][CH:13]=2)=[N:24][C:23]([NH2:25])=[N:22][C:26]=1[S:27][CH3:29])=[O:5])[CH3:8] |f:1.2,4.5|']","['US20010027196A1', '2-Amino-4-furan-2-yl-6-methylsulfanyl-pyrimidine-5-carboxylic acid ethyl ester', '1024', 'From ethyl beta-oxo-2-furanpropionate with sodium hydride, carbon disulphide and methyl iodide in DMSO. Then treatment with guanidine nitrate and triethylamine in DMF. EI-MS m/e (%): 279 (M+, 100), 234 ([M—EtO]+, 88), 233 ([M—EtOH]+, 48), 206 (62).']","[{'chemical_names': ['ethyl beta-oxo-2-furanpropionate'], 'identifiers': ['smiles:CCOC(=O)CC(=O)c1ccco1', 'inchi:InChI=1S/C9H10O4/c1-2-12-9(11)6-7(10)8-4-3-5-13-8/h3-5H,2,6H2,1H3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['sodium hydride'], 'identifiers': ['smiles:[H-].[Na+]', 'inchi:InChI=1S/Na.H/q+1;-1'], 'amounts': [], 'appearances': []}, {'chemical_names': ['methyl iodide'], 'identifiers': ['smiles:CI', 'inchi:InChI=1S/CH3I/c1-2/h1H3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['guanidine nitrate'], 'identifiers': ['smiles:N=C(N)N.O=[N+]([O-])O', 'inchi:InChI=1S/CH5N3.HNO3/c2*2-1(3)4/h(H5,2,3,4);(H,2,3,4)'], 'amounts': [], 'appearances': []}, {'chemical_names': ['M—EtO'], 'identifiers': [], 'amounts': [], 'appearances': []}, {'chemical_names': ['M—EtOH'], 'identifiers': [], 'amounts': [], 'appearances': []}, {'chemical_names': ['( 62 )'], 'identifiers': [], 'amounts': [], 'appearances': []}, {'chemical_names': ['DMSO'], 'identifiers': ['smiles:CS(C)=O', 'inchi:InChI=1S/C2H6OS/c1-4(2)3/h1-2H3'], 'amounts': [], 'appearances': []}]","[{'chemical_names': ['2-Amino-4-furan-2-yl-6-methylsulfanyl-pyrimidine-5-carboxylic acid ethyl ester'], 'identifiers': ['smiles:CCOC(=O)c1c(SC)nc(N)nc1-c1ccco1', 'inchi:InChI=1S/C12H13N3O3S/c1-3-17-11(16)8-9(7-5-4-6-18-7)14-12(13)15-10(8)19-2/h4-6H,3H2,1-2H3,(H2,13,14,15)'], 'amounts': [], 'appearances': []}]","[{'chemical_names': ['DMF'], 'identifiers': ['smiles:CN(C)C=O', 'inchi:InChI=1S/C3H7NO/c1-4(2)3-5/h3H,1-2H3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['triethylamine'], 'identifiers': ['smiles:CCN(CC)CC', 'inchi:InChI=1S/C6H15N/c1-4-7(5-2)6-3/h4-6H2,1-3H3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['carbon disulphide'], 'identifiers': ['smiles:S=C=S', 'inchi:InChI=1S/CS2/c2-1-3'], 'amounts': [], 'appearances': []}]",[],[]
"['C(O[C:4]([C:6]1[O:10][N:9]=[CH:8][CH:7]=1)=O)C.[CH2:11]([Li])[CH2:12][CH2:13]C.[H-].[Na+].CI.[N+:20]([O-])(O)=O.[NH2:24][C:25]([NH2:27])=[NH:26].C[S:29]([CH3:31])=O', 'C1COCC1.CN(C=O)C.C(N(CC)CC)C.C(=S)=S.C(#N)C', '[NH2:26][C:25]1[N:27]=[C:4]([C:6]2[O:10][N:9]=[CH:8][CH:7]=2)[C:12]([C:13]#[N:20])=[C:11]([S:29][CH3:31])[N:24]=1 |f:2.3,5.6|']","['US20010027196A1', '2-Amino-4-isoxazol-5-yl-6-methylsulfanyl-pyrimidine-5-carbonitrile', '1701', 'From isoxazole-5-carboxylic acid ethyl ester with acetonitrile and butyllithium in THF. Then treatment with sodium hydride, carbon disulphide and methyl iodide in DMSO. Then treatment with guanidine nitrate and triethylamine in DMF. EI-MS m/e (%): 233 (M+, 45), 206 ([M—HCN]+, 100), 151 (33).']","[{'chemical_names': ['isoxazole-5-carboxylic acid ethyl ester'], 'identifiers': ['smiles:CCOC(=O)c1ccno1', 'inchi:InChI=1S/C6H7NO3/c1-2-9-6(8)5-3-4-7-10-5/h3-4H,2H2,1H3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['butyllithium'], 'identifiers': ['smiles:[Li]CCCC', 'inchi:InChI=1S/C4H9.Li/c1-3-4-2;/h1,3-4H2,2H3;'], 'amounts': [], 'appearances': []}, {'chemical_names': ['sodium hydride'], 'identifiers': ['smiles:[H-].[Na+]', 'inchi:InChI=1S/Na.H/q+1;-1'], 'amounts': [], 'appearances': []}, {'chemical_names': ['methyl iodide'], 'identifiers': ['smiles:CI', 'inchi:InChI=1S/CH3I/c1-2/h1H3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['guanidine nitrate'], 'identifiers': ['smiles:N=C(N)N.O=[N+]([O-])O', 'inchi:InChI=1S/CH5N3.HNO3/c2*2-1(3)4/h(H5,2,3,4);(H,2,3,4)'], 'amounts': [], 'appearances': []}, {'chemical_names': ['M—HCN'], 'identifiers': [], 'amounts': [], 'appearances': []}, {'chemical_names': ['( 33 )'], 'identifiers': [], 'amounts': [], 'appearances': []}, {'chemical_names': ['DMSO'], 'identifiers': ['smiles:CS(C)=O', 'inchi:InChI=1S/C2H6OS/c1-4(2)3/h1-2H3'], 'amounts': [], 'appearances': []}]","[{'chemical_names': ['2-Amino-4-isoxazol-5-yl-6-methylsulfanyl-pyrimidine-5-carbonitrile'], 'identifiers': ['smiles:CSc1nc(N)nc(-c2ccno2)c1C#N', 'inchi:InChI=1S/C9H7N5OS/c1-16-8-5(4-10)7(13-9(11)14-8)6-2-3-12-15-6/h2-3H,1H3,(H2,11,13,14)'], 'amounts': [], 'appearances': []}]","[{'chemical_names': ['THF'], 'identifiers': ['smiles:C1CCOC1', 'inchi:InChI=1S/C4H8O/c1-2-4-5-3-1/h1-4H2'], 'amounts': [], 'appearances': []}, {'chemical_names': ['DMF'], 'identifiers': ['smiles:CN(C)C=O', 'inchi:InChI=1S/C3H7NO/c1-4(2)3-5/h3H,1-2H3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['triethylamine'], 'identifiers': ['smiles:CCN(CC)CC', 'inchi:InChI=1S/C6H15N/c1-4-7(5-2)6-3/h4-6H2,1-3H3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['carbon disulphide'], 'identifiers': ['smiles:S=C=S', 'inchi:InChI=1S/CS2/c2-1-3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['acetonitrile'], 'identifiers': ['smiles:CC#N', 'inchi:InChI=1S/C2H3N/c1-2-3/h1H3'], 'amounts': [], 'appearances': []}]",[],[]
"['[O:1]1[CH:5]=[CH:4][CH:3]=[C:2]1[C:6]([C:8](=[C:11]([S:14][CH3:15])SC)[C:9]#[N:10])=O.N[N:17]=[CH:18][NH:19][C:20](=[O:27])[C:21]1[CH:26]=[CH:25][CH:24]=[CH:23][CH:22]=1.C([N:30](CC)CC)C', 'CN(C=O)C', '[C:9]([C:8]1[C:6]([C:2]2[O:1][CH:5]=[CH:4][CH:3]=2)=[N:17][C:18]([NH:19][C:20](=[O:27])[C:21]2[CH:26]=[CH:25][CH:24]=[CH:23][CH:22]=2)=[N:30][C:11]=1[S:14][CH3:15])#[N:10]']","['US20010027196A1', '1730', 'Following the method of Rudorf and Augustin (J. Prakt. Chem. 1978, 320, 576), a solution of 250 mg (1.04 mmol) 2-(furan-2-carbonyl)-3,3-bis-methylsulfanyl-acrylonitrile, 205 mg (1.25 mmol) N-(aminoiminomethyl)benzamide and 0.36 ml (2.61 mmol) triethylamine in 5 ml DMF was heated at reflux for 6 h. The reaction mixture was then cooled to room temperature and partitioned between ethyl acetate and water. The phases were separated and the organic phase dried over sodium sulfate and concentrated in vacuo. Chromatography (hexane then ethyl acetate/hexane 1/1) afforded 199 mg (57%) N-(5-cyano-4-furan-2-yl-6-methylsulfanyl-pyrimidin-2-yl)-benzamide as an off-white amorphous solid. ES-MS m/e (%): 359 (M+Na+, 36), 337 (M+H+, 100).']","[{'chemical_names': ['2-(furan-2-carbonyl)-3,3-bis-methylsulfanyl-acrylonitrile'], 'identifiers': ['smiles:CSC(SC)=C(C#N)C(=O)c1ccco1', 'inchi:InChI=1S/C10H9NO2S2/c1-14-10(15-2)7(6-11)9(12)8-4-3-5-13-8/h3-5H,1-2H3'], 'amounts': ['1.04 mmol', '250 mg'], 'appearances': []}, {'chemical_names': ['N-(aminoiminomethyl)benzamide'], 'identifiers': ['smiles:NN=CNC(=O)c1ccccc1', 'inchi:InChI=1S/C8H9N3O/c9-11-6-10-8(12)7-4-2-1-3-5-7/h1-6H,9H2,(H,10,11,12)'], 'amounts': ['1.25 mmol', '205 mg'], 'appearances': []}, {'chemical_names': ['triethylamine'], 'identifiers': ['smiles:CCN(CC)CC', 'inchi:InChI=1S/C6H15N/c1-4-7(5-2)6-3/h4-6H2,1-3H3'], 'amounts': ['2.61 mmol', '0.36 ml'], 'appearances': []}]","[{'chemical_names': ['N-(5-cyano-4-furan-2-yl-6-methylsulfanyl-pyrimidin-2-yl)-benzamide'], 'identifiers': ['smiles:CSc1nc(NC(=O)c2ccccc2)nc(-c2ccco2)c1C#N', 'inchi:InChI=1S/C17H12N4O2S/c1-24-16-12(10-18)14(13-8-5-9-23-13)19-17(21-16)20-15(22)11-6-3-2-4-7-11/h2-9H,1H3,(H,19,20,21,22)'], 'amounts': ['199 mg', '57%', '56.9'], 'appearances': ['off-white amorphous']}]","[{'chemical_names': ['DMF'], 'identifiers': ['smiles:CN(C)C=O', 'inchi:InChI=1S/C3H7NO/c1-4(2)3-5/h3H,1-2H3'], 'amounts': ['5 ml'], 'appearances': []}]",[],"['step 1:a solution of 250 mg (1.04 mmol) 2-(furan-2-carbonyl)-3,3-bis-methylsulfanyl-acrylonitrile, 205 mg (1.25 mmol) N-(aminoiminomethyl)benzamide and 0.36 ml (2.61 mmol) triethylamine in 5 ml DMF was heated', 'step 2:at reflux for 6 h', 'step 2 properties:Time:21600', 'step 3:The reaction mixture was then cooled to room temperature', 'step 3 properties:Temperature:room temperature', 'step 4:partitioned between ethyl acetate and water', 'step 5:The phases were separated', 'step 6:the organic phase dried over sodium sulfate', 'step 7:concentrated in vacuo', 'step 8:Chromatography (hexane then ethyl acetate/hexane 1/1) afforded 199 mg (57%) N-(5-cyano-4-furan-2-yl-6-methylsulfanyl-pyrimidin-2-yl)-benzamide as an off-white amorphous solid']"
"['[NH2:1][C:2]1[N:7]=[C:6]([C:8]2[O:9][C:10](Br)=[CH:11][CH:12]=2)[C:5]([C:14]#[N:15])=[C:4]([S:16][CH3:17])[N:3]=1.C1([As](C2C=CC=CC=2)C2C=CC=CC=2)C=CC=CC=1.C(N(CC)CC)C.[CH2:44]([OH:46])[CH3:45].CN([CH:50]=[O:51])C', 'C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.[Pd]', '[CH2:44]([O:46][C:50]([C:10]1[O:9][C:8]([C:6]2[C:5]([C:14]#[N:15])=[C:4]([S:16][CH3:17])[N:3]=[C:2]([NH2:1])[N:7]=2)=[CH:12][CH:11]=1)=[O:51])[CH3:45] |f:5.6.7|']","['US20010027196A1', '1844', 'To a stirred solution of 1.17 g (3.74 mmol) 2-amino-4-(5-bromo-furan-2-yl)-6-methylsulfanyl-pyrimidine-5-carbonitrile in 15 ml DMF at room temperature were added 343 mg (0.37 mmol) tris(dibenzylideneacetone)dipalladium(O) and 287 mg (0.94 mmol) triphenylarsine. Carbon monoxide was bubbled through the reaction mixture for 10 min, then 2.61 ml (18.7 mmol) triethylamine and 10.9 ml (187 mmol) ethanol were added. The reaction mixture was then heated at 90° C. for 16 hours under a carbon monoxide atmosphere (balloon). The reaction mixture was then concentrated in vacuo. Flash chromatography (1/1 ethyl acetate/hexane then ethyl acetate) afforded 70 mg (6%) 5-(2-amino-5-cyano-6-methylsulfanyl-pyrimidin-4-yl)-furan-2-carboxylic acid ethyl ester as a yellow crystalline solid. EI-MS m/e (%): 304 (M+, 95), 303 ([M—H]+, 100), 275 (32), 259 (93), 231 (72), 202 (32).']","[{'chemical_names': ['2-amino-4-(5-bromo-furan-2-yl)-6-methylsulfanyl-pyrimidine-5-carbonitrile'], 'identifiers': ['smiles:CSc1nc(N)nc(-c2ccc(Br)o2)c1C#N', 'inchi:InChI=1S/C10H7BrN4OS/c1-17-9-5(4-12)8(14-10(13)15-9)6-2-3-7(11)16-6/h2-3H,1H3,(H2,13,14,15)'], 'amounts': ['3.74 mmol', '1.17 g'], 'appearances': []}, {'chemical_names': ['triphenylarsine'], 'identifiers': ['smiles:c1ccc([As](c2ccccc2)c2ccccc2)cc1', 'inchi:InChI=1S/C18H15As/c1-4-10-16(11-5-1)19(17-12-6-2-7-13-17)18-14-8-3-9-15-18/h1-15H'], 'amounts': ['0.94 mmol', '287 mg'], 'appearances': []}, {'chemical_names': ['triethylamine'], 'identifiers': ['smiles:CCN(CC)CC', 'inchi:InChI=1S/C6H15N/c1-4-7(5-2)6-3/h4-6H2,1-3H3'], 'amounts': ['18.7 mmol', '2.61 ml'], 'appearances': []}, {'chemical_names': ['ethanol'], 'identifiers': ['smiles:CCO', 'inchi:InChI=1S/C2H6O/c1-2-3/h3H,2H2,1H3'], 'amounts': ['187 mmol', '10.9 ml'], 'appearances': []}, {'chemical_names': ['DMF'], 'identifiers': ['smiles:CN(C)C=O', 'inchi:InChI=1S/C3H7NO/c1-4(2)3-5/h3H,1-2H3'], 'amounts': ['15 ml'], 'appearances': []}]","[{'chemical_names': ['5-(2-amino-5-cyano-6-methylsulfanyl-pyrimidin-4-yl)-furan-2-carboxylic acid ethyl ester'], 'identifiers': ['smiles:CCOC(=O)c1ccc(-c2nc(N)nc(SC)c2C#N)o1', 'inchi:InChI=1S/C13H12N4O3S/c1-3-19-12(18)9-5-4-8(20-9)10-7(6-14)11(21-2)17-13(15)16-10/h4-5H,3H2,1-2H3,(H2,15,16,17)'], 'amounts': ['70 mg', '6%'], 'appearances': ['yellow crystalline']}]",[],"[{'chemical_names': ['tris(dibenzylideneacetone)dipalladium(O)'], 'identifiers': ['smiles:O=C(/C=C/c1ccccc1)/C=C/c1ccccc1.O=C(/C=C/c1ccccc1)/C=C/c1ccccc1.[Pd]', 'inchi:InChI=1S/2C17H14O.Pd/c2*18-17(13-11-15-7-3-1-4-8-15)14-12-16-9-5-2-6-10-16;/h2*1-14H;/b2*13-11+,14-12+;'], 'amounts': ['0.37 mmol', '343 mg'], 'appearances': []}]","['step 1:To a stirred solution of 1.17 g (3.74 mmol) 2-amino-4-(5-bromo-furan-2-yl)-6-methylsulfanyl-pyrimidine-5-carbonitrile in 15 ml DMF at room temperature were added 343 mg (0.37 mmol) tris(dibenzylideneacetone)dipalladium(O) and 287 mg (0.94 mmol) triphenylarsine', 'step 1 properties:Temperature:room temperature', 'step 2:Carbon monoxide was bubbled through the reaction mixture for 10 min', 'step 2 properties:Time:600', 'step 3:2.61 ml (18.7 mmol) triethylamine and 10.9 ml (187 mmol) ethanol were added', 'step 4:The reaction mixture was then heated at 90° C. for 16 hours under a carbon monoxide atmosphere (balloon)', 'step 4 properties:Time:57600', 'step 4 properties:Temperature:90', 'step 5:The reaction mixture was then concentrated in vacuo', 'step 6:Flash chromatography (1/1 ethyl acetate/hexane then ethyl acetate) afforded 70 mg (6%) 5-(2-amino-5-cyano-6-methylsulfanyl-pyrimidin-4-yl)-furan-2-carboxylic acid ethyl ester as a yellow crystalline solid']"
"['[C:1]([C:3](=[C:13]([S:16][CH3:17])SC)[C:4]([C:6]1[O:10][C:9]([C:11]#[N:12])=[CH:8][CH:7]=1)=O)#[N:2].[N+]([O-])(O)=O.[NH2:22][C:23]([NH2:25])=[NH:24].C(N(CC)CC)C.O', 'CN(C=O)C', '[NH2:25][C:23]1[N:24]=[C:4]([C:6]2[O:10][C:9]([C:11]#[N:12])=[CH:8][CH:7]=2)[C:3]([C:1]#[N:2])=[C:13]([S:16][CH3:17])[N:22]=1 |f:1.2|']","['US20010027196A1', '1944', 'Following the method of Rudorf and Augustin (J. Prakt. Chem. 1978, 320, 576), a solution of 300 mg (1.13 mmol) 5-(2-cyano-3,3-bis-methylsulfanyl-acryloyl)-furan-2-carbonitrile, 166 mg (1,36 mmol) guanidine nitrate and 0.40 ml (2.84 mmol) triethylamine in 5 ml DMF was heated at reflux for 1 h. The reaction mixture was then cooled to room temperature and poured onto 250 ml water, extracted three times with ethyl acetate, and the combined organic phases dried over sodium sulfate and concentrated in vacuo. Chromatography (ethyl acetate) afforded 120 mg (41%) 2-amino-4-(5-cyano-furan-2-yl)-6-methylsulfanyl-pyrimidine-5-carbonitrile as a light yellow crystalline solid. ES-MS m/e (%): 256 ([M—H]−, 100).']","[{'chemical_names': ['5-(2-cyano-3,3-bis-methylsulfanyl-acryloyl)-furan-2-carbonitrile'], 'identifiers': ['smiles:CSC(SC)=C(C#N)C(=O)c1ccc(C#N)o1', 'inchi:InChI=1S/C11H8N2O2S2/c1-16-11(17-2)8(6-13)10(14)9-4-3-7(5-12)15-9/h3-4H,1-2H3'], 'amounts': ['1.13 mmol', '300 mg'], 'appearances': []}, {'chemical_names': ['guanidine nitrate'], 'identifiers': ['smiles:N=C(N)N.O=[N+]([O-])O', 'inchi:InChI=1S/CH5N3.HNO3/c2*2-1(3)4/h(H5,2,3,4);(H,2,3,4)'], 'amounts': ['1,36 mmol', '166 mg'], 'appearances': []}, {'chemical_names': ['triethylamine'], 'identifiers': ['smiles:CCN(CC)CC', 'inchi:InChI=1S/C6H15N/c1-4-7(5-2)6-3/h4-6H2,1-3H3'], 'amounts': ['2.84 mmol', '0.40 ml'], 'appearances': []}, {'chemical_names': ['water'], 'identifiers': ['smiles:O', 'inchi:InChI=1S/H2O/h1H2'], 'amounts': ['250 ml'], 'appearances': []}]","[{'chemical_names': ['2-amino-4-(5-cyano-furan-2-yl)-6-methylsulfanyl-pyrimidine-5-carbonitrile'], 'identifiers': ['smiles:CSc1nc(N)nc(-c2ccc(C#N)o2)c1C#N', 'inchi:InChI=1S/C11H7N5OS/c1-18-10-7(5-13)9(15-11(14)16-10)8-3-2-6(4-12)17-8/h2-3H,1H3,(H2,14,15,16)'], 'amounts': ['120 mg', '41%', '41.3'], 'appearances': ['light yellow crystalline']}]","[{'chemical_names': ['DMF'], 'identifiers': ['smiles:CN(C)C=O', 'inchi:InChI=1S/C3H7NO/c1-4(2)3-5/h3H,1-2H3'], 'amounts': ['5 ml'], 'appearances': []}]",[],"['step 1:a solution of 300 mg (1.13 mmol) 5-(2-cyano-3,3-bis-methylsulfanyl-acryloyl)-furan-2-carbonitrile, 166 mg (1,36 mmol) guanidine nitrate and 0.40 ml (2.84 mmol) triethylamine in 5 ml DMF was heated', 'step 2:at reflux for 1 h', 'step 2 properties:Time:3600', 'step 3:The reaction mixture was then cooled to room temperature', 'step 3 properties:Temperature:room temperature', 'step 4:poured onto 250 ml water', 'step 5:extracted three times with ethyl acetate', 'step 6:the combined organic phases dried over sodium sulfate', 'step 7:concentrated in vacuo', 'step 8:Chromatography (ethyl acetate) afforded 120 mg (41%) 2-amino-4-(5-cyano-furan-2-yl)-6-methylsulfanyl-pyrimidine-5-carbonitrile as a light yellow crystalline solid']"
"['CO[C:3]([C:5]1[O:6][CH:7]=[C:8]([C:10]#[N:11])[CH:9]=1)=O.[H-].[Na+].CI.[N+]([O-])(O)=O.[NH2:20][C:21]([NH2:23])=[NH:22].[C:24](=[S:26])=S', 'C1COCC1.CS(C)=O.CN(C=O)C.C(N(CC)CC)C.C(#N)C', '[NH2:22][C:21]1[N:23]=[C:3]([C:5]2[O:6][CH:7]=[C:8]([C:10]#[N:11])[CH:9]=2)[C:8]([C:10]#[N:11])=[C:7]([S:26][CH3:24])[N:20]=1 |f:1.2,4.5|']","['US20010027196A1', '2-Amino-4-(4-cyano-furan-2-yl)-6-methylsulfanyl-pyrimidine-5-carbonitrile', '1991', 'From 4-cyano-furan-2-carboxylic acid methyl ester with sodium hydride and acetonitrile in THF. Then treatment with sodium hydride, carbon disulphide and methyl iodide in DMSO. Then treatment with guanidine nitrate and triethylamine in DMF. EI-MS m/e (%): 257 (M+, 35), 256 ([M—H]+, 100).']","[{'chemical_names': ['4-cyano-furan-2-carboxylic acid methyl ester'], 'identifiers': ['smiles:COC(=O)c1cc(C#N)co1', 'inchi:InChI=1S/C7H5NO3/c1-10-7(9)6-2-5(3-8)4-11-6/h2,4H,1H3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['sodium hydride'], 'identifiers': ['smiles:[H-].[Na+]', 'inchi:InChI=1S/Na.H/q+1;-1'], 'amounts': [], 'appearances': []}, {'chemical_names': ['sodium hydride'], 'identifiers': ['smiles:[H-].[Na+]', 'inchi:InChI=1S/Na.H/q+1;-1'], 'amounts': [], 'appearances': []}, {'chemical_names': ['methyl iodide'], 'identifiers': ['smiles:CI', 'inchi:InChI=1S/CH3I/c1-2/h1H3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['guanidine nitrate'], 'identifiers': ['smiles:N=C(N)N.O=[N+]([O-])O', 'inchi:InChI=1S/CH5N3.HNO3/c2*2-1(3)4/h(H5,2,3,4);(H,2,3,4)'], 'amounts': [], 'appearances': []}, {'chemical_names': ['carbon disulphide'], 'identifiers': ['smiles:S=C=S', 'inchi:InChI=1S/CS2/c2-1-3'], 'amounts': [], 'appearances': []}]","[{'chemical_names': ['2-Amino-4-(4-cyano-furan-2-yl)-6-methylsulfanyl-pyrimidine-5-carbonitrile'], 'identifiers': ['smiles:CSc1nc(N)nc(-c2cc(C#N)co2)c1C#N', 'inchi:InChI=1S/C11H7N5OS/c1-18-10-7(4-13)9(15-11(14)16-10)8-2-6(3-12)5-17-8/h2,5H,1H3,(H2,14,15,16)'], 'amounts': [], 'appearances': []}]","[{'chemical_names': ['THF'], 'identifiers': ['smiles:C1CCOC1', 'inchi:InChI=1S/C4H8O/c1-2-4-5-3-1/h1-4H2'], 'amounts': [], 'appearances': []}, {'chemical_names': ['DMSO'], 'identifiers': ['smiles:CS(C)=O', 'inchi:InChI=1S/C2H6OS/c1-4(2)3/h1-2H3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['DMF'], 'identifiers': ['smiles:CN(C)C=O', 'inchi:InChI=1S/C3H7NO/c1-4(2)3-5/h3H,1-2H3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['triethylamine'], 'identifiers': ['smiles:CCN(CC)CC', 'inchi:InChI=1S/C6H15N/c1-4-7(5-2)6-3/h4-6H2,1-3H3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['acetonitrile'], 'identifiers': ['smiles:CC#N', 'inchi:InChI=1S/C2H3N/c1-2-3/h1H3'], 'amounts': [], 'appearances': []}]",[],[]
"['[O:1]1[CH:5]=[CH:4][CH:3]=[C:2]1[C:6]([C:8](=[C:11]([S:14][CH3:15])SC)[C:9]#[N:10])=O.[CH3:16][O:17][CH2:18][CH2:19][N:20]([CH2:22][C:23]1[CH:34]=[CH:33][C:26]([C:27]([NH:29][C:30]([NH2:32])=[NH:31])=[O:28])=[CH:25][CH:24]=1)[CH3:21].C(N(CC)CC)C', 'CN(C=O)C', '[C:9]([C:8]1[C:6]([C:2]2[O:1][CH:5]=[CH:4][CH:3]=2)=[N:31][C:30]([NH:29][C:27](=[O:28])[C:26]2[CH:25]=[CH:24][C:23]([CH2:22][N:20]([CH2:19][CH2:18][O:17][CH3:16])[CH3:21])=[CH:34][CH:33]=2)=[N:32][C:11]=1[S:14][CH3:15])#[N:10]']","['US20010027196A1', 'N-(5-Cyano-4-furan-2-yl-6-methylsulfanyl-pyrimidin-2-yl)-4-{[(2-methoxy-ethyl)-methyl-amino]-methyl}-benzamide', '2011', 'From 2-(furan-2-carbonyl)-3,3-bis-methylsulfanyl-acrylonitrile, N-(4-{[(2-methoxy-ethyl)-methyl-amino]-methyl}-benzoyl)-guanidine and triethylamine in DMF. ES-MS m/e (%): 438 (M+H+, 100).']","[{'chemical_names': ['2-(furan-2-carbonyl)-3,3-bis-methylsulfanyl-acrylonitrile'], 'identifiers': ['smiles:CSC(SC)=C(C#N)C(=O)c1ccco1', 'inchi:InChI=1S/C10H9NO2S2/c1-14-10(15-2)7(6-11)9(12)8-4-3-5-13-8/h3-5H,1-2H3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['N-(4-{[(2-methoxy-ethyl)-methyl-amino]-methyl}-benzoyl)-guanidine'], 'identifiers': ['smiles:COCCN(C)Cc1ccc(C(=O)NC(=N)N)cc1', 'inchi:InChI=1S/C13H20N4O2/c1-17(7-8-19-2)9-10-3-5-11(6-4-10)12(18)16-13(14)15/h3-6H,7-9H2,1-2H3,(H4,14,15,16,18)'], 'amounts': [], 'appearances': []}, {'chemical_names': ['triethylamine'], 'identifiers': ['smiles:CCN(CC)CC', 'inchi:InChI=1S/C6H15N/c1-4-7(5-2)6-3/h4-6H2,1-3H3'], 'amounts': [], 'appearances': []}]","[{'chemical_names': ['N-(5-Cyano-4-furan-2-yl-6-methylsulfanyl-pyrimidin-2-yl)-4-{[(2-methoxy-ethyl)-methyl-amino]-methyl}-benzamide'], 'identifiers': ['smiles:COCCN(C)Cc1ccc(C(=O)Nc2nc(SC)c(C#N)c(-c3ccco3)n2)cc1', 'inchi:InChI=1S/C22H23N5O3S/c1-27(10-12-29-2)14-15-6-8-16(9-7-15)20(28)25-22-24-19(18-5-4-11-30-18)17(13-23)21(26-22)31-3/h4-9,11H,10,12,14H2,1-3H3,(H,24,25,26,28)'], 'amounts': [], 'appearances': []}]","[{'chemical_names': ['DMF'], 'identifiers': ['smiles:CN(C)C=O', 'inchi:InChI=1S/C3H7NO/c1-4(2)3-5/h3H,1-2H3'], 'amounts': [], 'appearances': []}]",[],[]
"['[CH3:1][O:2][C:3]1[C:4](C(O)=O)=[CH:5][C:6]2[C:11]([CH:12]=1)=[CH:10][CH:9]=[CH:8][CH:7]=2.CC[N:18]([CH2:21]C)CC.C1C=CC(P(N=[N+]=[N-])(C2C=CC=CC=2)=[O:30])=CC=1.[CH2:40]([OH:47])[C:41]1[CH:46]=[CH:45][CH:44]=[CH:43][CH:42]=1', 'C1(C)C=CC=CC=1', '[C:21]([NH:18][C:5]1[C:6]2[C:11](=[CH:10][CH:9]=[CH:8][CH:7]=2)[CH:12]=[C:3]([O:2][CH3:1])[CH:4]=1)([O:47][CH2:40][C:41]1[CH:46]=[CH:45][CH:44]=[CH:43][CH:42]=1)=[O:30]']","['US20010027202A1', '0066', 'A solution of 3-methoxy-2-naphthoic acid (3.36 g, 16.6 mmol) and Et3N (2.59 mL, 18.6 mmol) in anh toluene (70 mL) was stirred at room temp. for 15 min., then treated with a solution of DPPA (5.12 g, 18.6 mmol) in toluene (10 mL) via pipette. The resulting mixture was heated at 80° C. for 2 h. After cooling the mixture to room temp., benzyl alcohol (2.06 mL, 20 mmol) was added via syringe. The mixture was then warmed to 80° C. overnight. The resulting mixture was cooled to room temp., quenched with a 10% citric acid solution, and extracted with EtOAc (2×100 mL). The combined organic layers were washed with a saturated NaCl solution, dried (MgSO4) and concentrated under reduced pressure. The residue was purified by column chromatography (14% EtOAc/86% hexane) to give 2-(N-(carbobenzyloxy)amino-3-methoxynaphthalene as a pale yellow oil (5.1 g, 100%): 1H-NMR (DMSO-d6) δ3.89 (s, 3H), 5.17 (s, 2H), 7.27-7.44 (m, 8H), 7.72-7.75 (m, 2H), 8.20 (s, 1H), 8.76 (s, 1H).']","[{'chemical_names': ['3-methoxy-2-naphthoic acid'], 'identifiers': ['smiles:COc1cc2ccccc2cc1C(=O)O', 'inchi:InChI=1S/C12H10O3/c1-15-11-7-9-5-3-2-4-8(9)6-10(11)12(13)14/h2-7H,1H3,(H,13,14)'], 'amounts': ['16.6 mmol', '3.36 g'], 'appearances': []}, {'chemical_names': ['Et3N'], 'identifiers': ['smiles:CCN(CC)CC', 'inchi:InChI=1S/C6H15N/c1-4-7(5-2)6-3/h4-6H2,1-3H3'], 'amounts': ['18.6 mmol', '2.59 mL'], 'appearances': []}, {'chemical_names': ['DPPA'], 'identifiers': ['smiles:[N-]=[N+]=NP(=O)(c1ccccc1)c1ccccc1', 'inchi:InChI=1S/C12H10N3OP/c13-14-15-17(16,11-7-3-1-4-8-11)12-9-5-2-6-10-12/h1-10H'], 'amounts': ['18.6 mmol', '5.12 g'], 'appearances': []}, {'chemical_names': ['benzyl alcohol'], 'identifiers': ['smiles:OCc1ccccc1', 'inchi:InChI=1S/C7H8O/c8-6-7-4-2-1-3-5-7/h1-5,8H,6H2'], 'amounts': ['20 mmol', '2.06 mL'], 'appearances': []}]","[{'chemical_names': ['N-(carbobenzyloxy)amino-3-methoxynaphthalene'], 'identifiers': ['smiles:COc1cc(NC(=O)OCc2ccccc2)c2ccccc2c1', 'inchi:InChI=1S/C19H17NO3/c1-22-16-11-15-9-5-6-10-17(15)18(12-16)20-19(21)23-13-14-7-3-2-4-8-14/h2-12H,13H2,1H3,(H,20,21)'], 'amounts': ['5.1 g', '100%', '100.0'], 'appearances': ['pale yellow']}]","[{'chemical_names': ['toluene'], 'identifiers': ['smiles:Cc1ccccc1', 'inchi:InChI=1S/C7H8/c1-7-5-3-2-4-6-7/h2-6H,1H3'], 'amounts': ['70 mL'], 'appearances': []}, {'chemical_names': ['toluene'], 'identifiers': ['smiles:Cc1ccccc1', 'inchi:InChI=1S/C7H8/c1-7-5-3-2-4-6-7/h2-6H,1H3'], 'amounts': ['10 mL'], 'appearances': []}]",[],"['step 1:A solution of 3-methoxy-2-naphthoic acid (3.36 g, 16.6 mmol) and Et3N (2.59 mL, 18.6 mmol) in anh toluene (70 mL) was stirred at room temp. for 15 min.', 'step 1 properties:Time:900', 'step 1 properties:Temperature:room temperature', 'step 2:treated with a solution of DPPA (5.12 g, 18.6 mmol) in toluene (10 mL) via pipette', 'step 3:The resulting mixture was heated at 80° C. for 2 h', 'step 3 properties:Time:7200', 'step 3 properties:Temperature:80', 'step 4:After cooling the mixture to room temp.', 'step 4 properties:Temperature:room temperature', 'step 5:benzyl alcohol (2.06 mL, 20 mmol) was added via syringe', 'step 6:The mixture was then warmed to 80° C. overnight', 'step 6 properties:Time:overnight', 'step 6 properties:Temperature:80', 'step 7:The resulting mixture was cooled to room temp.', 'step 7 properties:Temperature:room temperature', 'step 8:quenched with a 10% citric acid solution', 'step 9:extracted with EtOAc (2×100 mL)', 'step 10:The combined organic layers were washed with a saturated NaCl solution', 'step 11:dried (MgSO4)', 'step 12:concentrated under reduced pressure', 'step 12 properties:Pressure:reduced pressure', 'step 13:The residue was purified by column chromatography (14% EtOAc/86% hexane)', 'step 14:to give 2-(N-(carbobenzyloxy)amino-3-methoxynaphthalene as a pale yellow oil (5.1 g, 100%)']"
"['[CH3:1][C:2]1[CH:8]=[C:7]([O:9][C:10]2[CH:15]=[CH:14][N:13]=[C:12]([C:16](=[O:19])[NH:17][CH3:18])[CH:11]=2)[CH:6]=[CH:5][C:3]=1[NH2:4].CCN(CC)CC.[Cl:27][C:28]1[CH:33]=[CH:32][C:31]([N:34]=[C:35]=[O:36])=[CH:30][C:29]=1[C:37]([F:40])([F:39])[F:38].O', 'C(Cl)Cl', '[Cl:27][C:28]1[CH:33]=[CH:32][C:31]([NH:34][C:35]([NH:4][C:3]2[CH:5]=[CH:6][C:7]([O:9][C:10]3[CH:15]=[CH:14][N:13]=[C:12]([C:16](=[O:19])[NH:17][CH3:18])[CH:11]=3)=[CH:8][C:2]=2[CH3:1])=[O:36])=[CH:30][C:29]=1[C:37]([F:38])([F:39])[F:40]']","['US20010027202A1', '0188', 'A solution of 2-methyl-4-(2-(N-methylcarbamoyl)(4-pyridyloxy))aniline (Method A5; 0.11 g, 0.45 mmol) in CH2Cl2 (1 mL) was treated with Et3N (0.16 mL) and 4-chloro-3-(trifluoromethyl)phenyl isocyanate (0.10 g, 0.45 mmol). The resulting brown solution was stirred at room temp. for 6 d, then was treated with water (5 mL). The aqueous layer was back-extracted with EtOAc (3×5 mL). The combined organic layers were dried (MgSO4) and concentrated under reduced pressure to yield N-(4-chloro-3-(trifluoromethyl)phenyl)-N′-(2-methyl-4-(2-(N-methylcarbamoyl)(4-pyridyloxy))phenyl) urea as a brown oil (0.11 g, 0.22 mmol): 1H NMR (DMSO-d6) δ2.27 (s, 3H), 2.77 (d, J=4.8 Hz, 3H), 7.03 (dd, J=8.5, 2.6 Hz, 1H), 7.11 (d, J=2.9 Hz, 1H), 7.15 (dd, J=5.5, 2.6, Hz, 1H), 7.38 (d, J=2.6 Hz, 1H), 7.62 (app d, J=2.6 Hz, 2H), 7.84 (d, J=8.8 Hz, 1H), 8.12 (s, 1H), 8.17 (s, 1H); 8.50 (d, J=5.5 Hz, 1H), 8.78 (q, J=5.2, 1H), 9.52 (s, 1H); HPLC ES-MS m/z 479 ((M+H)+).']","[{'chemical_names': ['2-methyl-4-(2-(N-methylcarbamoyl)(4-pyridyloxy))aniline'], 'identifiers': ['smiles:CNC(=O)c1cc(Oc2ccc(N)c(C)c2)ccn1', 'inchi:InChI=1S/C14H15N3O2/c1-9-7-10(3-4-12(9)15)19-11-5-6-17-13(8-11)14(18)16-2/h3-8H,15H2,1-2H3,(H,16,18)'], 'amounts': ['0.45 mmol', '0.11 g'], 'appearances': []}, {'chemical_names': ['Et3N'], 'identifiers': ['smiles:CCN(CC)CC', 'inchi:InChI=1S/C6H15N/c1-4-7(5-2)6-3/h4-6H2,1-3H3'], 'amounts': ['0.16 mL'], 'appearances': []}, {'chemical_names': ['4-chloro-3-(trifluoromethyl)phenyl isocyanate'], 'identifiers': ['smiles:O=C=Nc1ccc(Cl)c(C(F)(F)F)c1', 'inchi:InChI=1S/C8H3ClF3NO/c9-7-2-1-5(13-4-14)3-6(7)8(10,11)12/h1-3H'], 'amounts': ['0.45 mmol', '0.10 g'], 'appearances': []}, {'chemical_names': ['water'], 'identifiers': ['smiles:O', 'inchi:InChI=1S/H2O/h1H2'], 'amounts': ['5 mL'], 'appearances': []}]","[{'chemical_names': ['N-(4-chloro-3-(trifluoromethyl)phenyl)-N′-(2-methyl-4-(2-(N-methylcarbamoyl)(4-pyridyloxy))phenyl) urea'], 'identifiers': ['smiles:CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(C)c2)ccn1', 'inchi:InChI=1S/C22H18ClF3N4O3/c1-12-9-14(33-15-7-8-28-19(11-15)20(31)27-2)4-6-18(12)30-21(32)29-13-3-5-17(23)16(10-13)22(24,25)26/h3-11H,1-2H3,(H,27,31)(H2,29,30,32)'], 'amounts': ['0.22 mmol', '0.11 g', '48.9'], 'appearances': ['brown']}]","[{'chemical_names': ['CH2Cl2'], 'identifiers': ['smiles:ClCCl', 'inchi:InChI=1S/CH2Cl2/c2-1-3/h1H2'], 'amounts': ['1 mL'], 'appearances': []}]",[],"['step 1:A solution of 2-methyl-4-(2-(N-methylcarbamoyl)(4-pyridyloxy))aniline (Method A5; 0.11 g, 0.45 mmol) in CH2Cl2 (1 mL) was treated with Et3N (0.16 mL) and 4-chloro-3-(trifluoromethyl)phenyl isocyanate (0.10 g, 0.45 mmol)', 'step 2:The resulting brown solution was stirred at room temp. for 6 d', 'step 2 properties:Time:518400', 'step 2 properties:Temperature:room temperature', 'step 3:was treated with water (5 mL)', 'step 4:The aqueous layer was back-extracted with EtOAc (3×5 mL)', 'step 5:The combined organic layers were dried (MgSO4)', 'step 6:concentrated under reduced pressure', 'step 6 properties:Pressure:reduced pressure', 'step 7:to yield N-(4-chloro-3-(trifluoromethyl)phenyl)-N′-(2-methyl-4-(2-(N-methylcarbamoyl)(4-pyridyloxy))phenyl) urea as a brown oil (0.11 g, 0.22 mmol)']"
